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- PREFACE 
A symposium e n t i t l e d  "Hyperthermia a s  an Antineoplast ic  Treatment 
Modality" was held a t  t h e  Omni I n t e r n a t i o n a l  Hotel,  Norfolk, Vi rg in ia ,  on 
Saturday, January 28, 1978. The sponsors were t h e  National Aeronautics and 
Space Administration, Langley Research Center ( L ~ R C ) ,  Hampton, Virgin ia ,  
and the  Eastern Virgin ia  Medical School (EVMS), Department of Radiation 
Oncology and Biophysics, Norfolk, Virgin ia .  
Since October 1976 the  Langley Research Center has been working i n  a 
co l l abora t ive  biomedical app l i ca t ion  p r o j e c t  with both the  Eastern Virgin ia  
Medical School and t h e  Medical College of Virgin ia  (MCV), Richmond, 
Virgin ia ,  t o  develop improved methods of t r e a t i n g  tumorous cancers with 
hyperthermia. The LaRC has f a b r i c a t e d  radio-frequency heat ing  equipment 
and a l s o  thermal measuring equipment. The MCV and EXMS a r e  p resen t ly  eval-  
ua t ing  t h e s e  systems i n  p r e c l i n i c a l  experiments. The LaRC i s  a l s o  
developing (under c o n t r a c t  t o  Microwave Associates,  Inc. ,  Burlington, 
Massachusetts) a noninvasive device t h a t  w i l l  provide microwave heat ing  and 
simultaneous temperature monitoring of cancerous t i s s u e s .  The MCV and EVMS 
plan  t o  evaluate  t h i s  device during t h e  summer of 1978. 
The purpose of t h i s  symposium was t o  provide an opportunity f o r  t h e  
LaRC, EVMS, and MCV t o  d iscuss  t h e i r  progress t o  d a t e  and a l s o  t o  meet 
together  with Microwave Associates,  Inc . ,  t o  d i scuss  t h e i r  f u t u r e  programs. 
Medical researchers  from the  National Cancer I n s t i t u t e ,  Veterans Adminis- 
t r a t i o n ,  Universi ty of Virgin ia  Medical School, and Universi ty of Maryland 
School of Medicine, who have a l s o  been inves t iga t ing  hyperthermia f o r  
cancer therapy,  were a l s o  i n v i t e d  t o  p a r t i c i p a t e .  
Tne format of t h e  symposium was a s  follows: two review papers,  four 
s c i e n t i f i c  papers,  one c l i n i c a l  paper, and four  open-discussion sess ions .  
The open-discussion sess ions  were e n t i t l e d  "Methods of Heating," "Thermal 
Measurements," " P r e c l i n i c a l  Experiments," and "Cl in ica l  T r i a l s , "  respec- 
t i v e l y .  The ques t ions  and answers fol lowing each of t h e  seven presented 
papers and a l s o  t h e  four  open-discussion sess ions  were recorded, t ran-  
scr ibed,  and e d i t e d  and have been included i n  t h i s  publ ica t ion .  
May 1978 Shei la  Ann T. Long 
National Aeronautics 
and Space Administration 
Langley Research Center 
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HYPERTHERMIA AS AN ANTINEOPLASTIC TREATMENT MODALITY 
F r a n c i s  E. Rosato 
Eas t e rn  V i r g i n i a  Medical School 
I NTRODUCTORY REMARKS 
I am ve ry  p l ea sed  t o  have t h e  occas ion  t o  welcome you 
he re  f o r  t h i s  Symposium convened t o  d i s c u s s  t h e  c u r r e n t  s t a t u s  
of hyperthermia i n  t h e  t rea tment  of  malignant tumors. You may 
wonder why I ,  P ro fe s so r  and Chairman of t h e  Department o f  Sur- 
gery  a t  Eas t e rn  V i r g i n i a  Medical School ,  has  been asked t o  
make t h e s e  i n t r o d u c t o r y  comments, and t h e  b e s t  reason t h a t  I 
can come up w i t h  is t h a t  I have been i n  "hot s p o t s "  a t  least 
once weekly f o r  t h e  l a s t  t e n  yea r s .  Ac tua l ly ,  I am h e r e  
r e p r e s e n t i n g  both ou r  Dean, Gerald  Holman, and D r .  Donald 
Merchant, P ro fe s so r  and Chairman of  t h e  Department of Micro- 
b io logy ,  who is D i r e c t o r  of t h e  Tidewater Regional  Planning 
Cancer Cente r .  
We have come a long way s i n c e  t h e  c rude  i n i t i a l  e f f o r t s  
i nvo lv ing  Co ley ' s  t o x i n  i n  t h e  t r ea tmen t  of advanced malig- 
nanc i e s .  J u s t  t h r e e  days ago I performed an i s o l a t i o n  per-  
fu s ion  of an  ex t r emi ty  u s ing  hyper thermic p e r f u s a t e  a s  p a r t  
of t h e  t rea tment  of an ex t r emi ty  sarcoma. I n v e s t i g a t o r s  i n  
g r e a t e r  and g r e a t e r  numbers a r e  a t t a c k i n g  t h e  conceptua l  and 
t e c h n i c a l  problems t h a t  r e l a t e  t o  t h e  u t i l i z a t i o n  of hyper- 
thermic techniques  i n  tumor t r ea tmen t .  
I wish t o  thank  p a r t i c u l a r l y  D r s .  h a s  El-Mahdi and 
James S h a e f f e r ,  as w e l l  a s  M r .  Jack Wakley f o r  t ak ing  t h e  
r e s p o n s i b i l i t y  of b r ing ing  a l l  of you t o g e t h e r .  I look 
forward wi th  i n t e r e s t  and enthusiasm t o  t h e  s e s s i o n  today. I am 
c o n f i d e n t  t h a t  meetings such a s  t h i s  wi th  t h e  exchange of 
t ime ly  and p e r t i n e n t  in format ion  a r e  one of t h e  most e f f e c t i v e  
ways  t o  advance both  t h e  unders tanding and a p p l i c a t i o n  of 
hyper thermia i n t o  t h e  a r e a s  of human tumor t r e a t m e n t .  

HYPERTHERMIA I N  THE TREATMENT OF CANCER 
A REVIEW OF THE RADIOBIOLOGICAL BASIS 
Donald G. Baker 
Div is ion  of Radia t ion  Oncology 
Un ive r s i t y  of V i r g i n i a  Hosp i t a l  
SUMMARY 
Temperatures i n  t h e  range 41.5OC t o  43.5OC tend  t o  b e  more damaging t o  
malignant t han  nonmalignant c e l l s .  Where l o c a l  hyperthermia (41. ~ O C  t o  43.5'~) 
i s  combined wi th  i o n i z i n g  r a d i a t i o n ,  a  s i g n i f i c a n t  t h e r a p e u t i c  r a t i o  may b e  
r e a l i z e d .  T o t a l  body hyperthermia, a lone  o r  combined wi th  o t h e r  t h e r a p e u t i c  
moda l i t i e s ,  can provide  p a l l i a t i o n  f o r  some systemic malignancies  bu t  may no t  
be as e f f e c t i v e  a s  l o c a l  hyperthermia f o r  t r e a t i n g  l o c a l  d i sease .  The i n f l u -  
ence of hyperthermia on immune mechanisms and t h e  r i s k  of m e t a s t a t i c  spread 
of p o t e n t i a l  tumor growth s t i m u l a t i o n  need f u r t h e r  i n v e s t i g a t i o n .  Among o t h e r  
ques t ions  needing e l u c i d a t i o n  be fo re  hyperthermia can b e  considered a  s tandard  
t reatment  modal i ty  a r e  t h e  time-dose ( f o r  hea t ing )  r e l a t i o n s h i p s  t o  produce an 
opt imal  t h e r a p e u t i c  r a t i o  and whether t h e  l a t e  sequela  of combined hea t  and 
ion iz ing  r a d i a t i o n  may r e s u l t  i n  an unacceptable  r i s k  of p a t i e n t  morbidi ty .  
INTRODUCTION 
Radia t ion  therapy  may f a i l  t o  achieve  l o c a l  c o n t r o l  of a  cancer  e i t h e r  
because of geographic m i s s  o r  because of i n s u f f i c i e n t  t o t a l  dose o r  time-dose, 
o r  both.  I n  t h e  l a t t e r  case ,  i t  may n o t  be  p o s s i b l e  t o  d e l i v e r  a  dose of 
r a d i a t i o n  l a r g e  enough t o  s t e r i l i z e  a l l  t h e  clonogenic c e l l s  because some 
c r i t i c a l  organ i n  t h e  t r e a t e d  volume, e .g . ,  s p i n a l  cord,  w i l l  r e c e i v e  an 
i n t o l e r a b l e  dose. Another p o s s i b l e  r ea son  f o r  l o c a l  f a i l u r e  is  t h e  presence  
of hypoxic f o c i  of tumor c e l l s  whose low r a d i o s e r ~ s i t i v i t y  r e s u l t s  i n  a  
s i g n i f i c a n t  number of surv iv ing  c e l l s  when t h e  t o l e r a n c e  dose has  been de- 
l i v e r e d .  Another c o n t r i b u t i n g  f a c t o r  could b e  t h e  inhe ren t  capac i ty  of c e l l s  
from tumors of c e r t a i n  h i s t o l o g i e s  t o  r e p a i r  a  l a r g e  propor t ion  of r a d i a t i o n  
i n j u r y  fo l lowing  each d a i l y  f r a c t i o n ,  A number of schemes have t h e r e f o r e  
been evolved e i t h e r  t o  i n c r e a s e  t h e  r a d i a t i o n  s e n s i t i v i t y  of t h e  tumor c e l l s  
o r  t o  dec rease  t h e  s e n s i t i v i t y  of t h e  normal t i s s u e s  i n  t h e  i r r a d i a t e d  volume, 
Hyperthermia is  a  technique  which has  p o t e n t i a l  f o r  i nc reas ing  t h e  the rapeu t i c  
r a t i o  by i n c r e a s i n g  t h e  r a d i o s e n s i t i v i t y  of tumor c e l l s .  
Hippocrates  descr ibed  a t  l eng th  t h e  b e n e f i c i a l  e f f e c t s  of hea t  and ho t  
ba ths  i n  main ta in ing  good h e a l t h  and a s  a t h e r a p e u t i c  regimen f o r  many d i s e a s e s ,  
It is  i n t e r e s t i n g  t o  s p e c u l a t e  whether i n  Japan, f o r  example, where many people 
t a k e  d a i l y  ho t  ba ths ,  t h e r e  is a  connect ion between t h i s  p r a c t i c e  and t h e  f a c t  
t h a t  t h e  n a t i o n a l  inc idence  of b r e a s t ,  p e n i l e ,  t e s t i c u l a r ,  and s k i n  cancers  i s  
among t h e  lowest  i n  t h e  world, The temperature of t h e s e  b a t h s  ranges from 
42OC t o  4 8 O ~  and r e s u l t s  i n  r e c t a l  temperatures  of  approximately 3g°C. (See 
r e f .  1.)  I n  F in land ,  where sauna ba th ing  i s  p r a c t i c e d ,  t h e  inc idence  of 
t e s t i c u l a r  and mammary cancer  i s  lower than  i n  neighboring c o u n t r i e s  where t h e  
sauna i s  n o t  used. (See r e f .  2.)  
For many y e a r s  t h e r e  have been c l i n i c a l  r e p o r t s  i n d i c a t i n g  t h a t  h e a t  h a s  
a  s e l e c t i v e l y  d e s t r u c t i v e  e f f e c t  on cancer  c e l l s  i n  v ivo  i n  comparison w i t h  
-- 
surrounding normal t i s s u e s .  
Some e a r l y  c l i n i c a l  r e p o r t s  reviewed by Selawry, -- e t  ala ( r e f .  3) and 
Caval ie re  -- e t  a 1  ( r e f .  4 )  i nc lude  an  1866 account desc r ib ing  h i s t o l o g i c a l l y  
proven sarcoma of t h e  f a c e  which regressed  a f t e r  h igh  f eve r  a s s o c i a t e d  w i t h  
s y p h i l i s .  The reviewers  a l s o  mentioned a  d i scuss ion  by Coley -- e t  a 1  ( r e f .  5) 
of 38 p a t i e n t s  wi th  advanced carcinoma who had an a s s o c i a t i o n  wi th  a c c i d e n t a l  
o r  d e l i b e r a t e  i n f e c t i o n s .  I n  t h i s  s e r i e s  t h e r e  was complete disappearance 
of t h e  tumors i n  12 ca ses ,  and a  s i g n i f i c a n t  r e g r e s s i o n  i n  19 cases .  A 
d e t a i l e d  review of t h i s  s tudy  was done by Nauts -- e t  a l . ( r e f .  6 ) .  
I n  V i t r o  S tud ie s  
When popula t ion  of c e l l s  a r e  exposed t o  a  s e r i e s  of graded doses of X-rays 
and t h e  percentage of su rv iv ing  c e l l s  counted, t h e  p l o t  of su rv iv ing  f r a c t i o n  
(S) on a  log  s c a l e  a g a i n s t  dose on a l i n e a r  s c a l e  y i e l d s  a  dose-ef fec t  
r e l a t i o n s h i p  cha rac t e r i zed  by an  i n i t i a l  shoulder  reg ion  a t  low doses and 
an  exponent ia l  r eg ion  a t  h igher  doses.  
The parameters of t h i s  r e l a t i o n s h i p ,  Do, Dq, and n ,  can be  used t o  d e f i n e  
t h e  r a d i o s e n s i t i v i t y  of t h e  c e l l s  a s  an e s t i m a t e  of t h e i r  capac i ty  t o  r e p a i r  
r a d i a t i o n  i n j u r y .  (See f i g .  1 . )  
I f  c e l l  popula t ions  a r e  incubated a t  e l eva t ed  temperatures  f o r  d i f f e r -  
e n t  pe r iods  of t ime, t h e  p ropor t ion  of c e l l s  su rv iv ing  t h e  hyperthermia 
may be  descr ibed  by us ing  a  n o t a t i o n  s i m i l a r  t o  t h a t  used f o r  s u r v i v a l  a f t e r  
X-radiation. 
Figure 2 ,  taken from r e p o r t  by Henle and Leeper ( r e f .  7) ,  i l l u s t r a t e s  t h e  
response of c e l l s  e i t h e r  t o  X-ray o r  hyperthermia. The s i m i l a r i t i e s  i n  shape 
of t h e  dose-response r e l a t i o n s h i p s  do no t  imply common mechanism of a c t i o n ,  
and c a r e  must be  exe rc i sed  n o t  t o  draw unwarranted conclus ions  by g iv ing  t h e  
s u r v i v a l  c h a r a c t e r i s t i c s  t h e  same i n t e r p r e t a t i o n  f o r  hyperthermia as f o r  
X-ray. 
An example of t h e  p o t e n t i a t i n g  e f f e c t  of hyperthermia on t h e  r a d i a t i o n  
response of CHO c e l l s  i s  shown i n  f i g u r e  3 taken from a r e p o r t  by Gerner 
( r e f ,  8 ) .  On t h e  r i g h t  s i d e  of t h e  f i g u r e  i s  shown t h e  e f f e c t  of i ncuba t ing  
t h e  c e l l s  a t  temperatures  up t o  43OC f o r  1 hour be fo re  t h e  X-radiation. The 
s o l i d  c i r c l e s  (upper curve) show t h e  response t o  r a d i a t i o n  a t  a  normal 
phys io log ica l  temperature,  37OC. Note t h a t  i nc reas ing  t h e  incuba t ion  
temperature up t o  43%C, a  tempera ture  which by i t s e l f  decreased c e l l  s u r v i v a l  
t o  20 pe r  c e n t ,  causes  a  dramatic  i n c r e a s e  i n  r a d i o s e n s i t i v i t y ,  i .e . ,  by a  
f a c t o r  of 2. 
A s  i n  many new i n v e s t i g a t i v e  procedures ,  r e s e a r c h e r s  have adopted a  
t e c h n i c a l  jargon.  One such express ion  is  t h e  thermal  enhancement r a t i o  o r  
TER. Th i s  is  g e n e r a l l y  t h e  r a t i o  of a  dose of X-ray o r  drug requi red  t o  
e l i c i t  a  given e f f e c t ,  compared w i t h  t h e  dose of t h e  same agent  r equ i r ed  t o  
g ive  t h e  i d e n t i c a l  e f f e c t  when combined w i t h  hyperthermia. 
The term can a l s o  b e  used t o  i n d i c a t e  t h e  r a t i o  of t h e  s lopes  of t h e  
exponent ia l  p o r t i o n s  of t h e  dose-response curves  when t h e  r e l a t i o n s h i p s  a r e  
determined w i t h  and without  hyperthermia. It can be  considered a s  analogous t o  
t h e  express ions  "dose-modifying f a c t o r s  (DMF)" o r  OER commonly used i n  
r a d i a t i o n  biology.  
I n  t h e  example j u s t  s t a t e d ,  t h e  thermal  enhancement r a t i o  would be  
ind ica t ed  a s  TER 43/1 hr. = = 2.2. 
65 
I n  t h i s  system, t h e  p o s t - i r r a d i a t i o n  h e a t i n g  d i d  not  r e s u l t  i n  a  TER 
s i g n i f i c a n t l y  d i f f e r e n t  from t h a t  found w i t h  p r e - i r r a d i a t i o n  hyperthermia. 
A t  temperatures  between 41,5OC and 43Oc, a  number of systems show tumor 
c e l l s  t o  b e  more s e n s i t i v e  t o  thermal  i n j u r y  than a r e  t h e  normal c e l l s  of t h e  
same o r i g i n .  Figure 4 ,  taken from a  r e p o r t  by Giovanella e t  a l A ( r e f .  9) i s  
r e p r e s e n t a t i v e  of a  l a r g e  body of information i n d i c a t i n g  t h i s  d i f f e r e n t i a l  
thermal s e n s i t i v i t y .  The optimum t h e r a p e u t i c  advantage probably w i l l  be  
obtained wi th  hyperthermia i n  t h e  range of 41.5OC t o  4 3 ' ~  and t h a t  t h e  d i f -  
f e r e n t i a l  e f f e c t  between tumor and normal c e l l s  may diminish a t  h igher  
temperatures .  
Thermodynamics cons ide ra t ions  suggest  t h e  p o s s i b i l i t y  t h a t  temperatures  
s l i g h t l y  i n  excess  of 3 7 ' ~  might prove s t i rnulatory t o  tumor c e l l  growth. 
Some i n  v i t r o  s t u d i e s  tend t o  support  t h i s  cond i t i on  ( r e f s .  10, 11, and 12) .  
Above 4 1 . 5 ' ~  a  c o n s i s t e n t  i n h i b i t o r y  e f f e c t  can be  demonstrated. I n  appl ica-  
t i o n s  of hyperthermia t o  c l i n i c a l  oncology ( t a b l e  l ) ,  temperatures  
between 41.5OC and 43.0°C a r e  thought t o  be opt imal  f o r  d i f f e r e n t i a l l y  sens i -  
t i z i n g  tumor c e l l s  t o  damage by i o n i z i n g  r a d i a t i o n .  
I n  some systems t h e  e f f e c t s  of combined X-ray and hyperthermia on c e l l  
s u r v i v a l  a r e  inf luenced  by t h e  sequence i n  which t h e  t rea tments  a r e  appl ied .  
Gerner -- e t  a l .  ( r e f .  13) found a  s l i g h t l y  increased  thermal enhancement of 
r a d i a t i o n  damage of CHO c e l l s  heated (one hour a t  43OC) immediately a f t e r  
i r r a d i a t i o n ,  bu t  noted an oppos i t e  response f o r  HeLa c e l l s .  Van d e r  Schueren 
1975 ( r e f .  14) ,  us ing  a  c e l l  l i n e  der ived  from u r e t e r a l  t i s s u e ,  found a  g r e a t e r  
thermal enhancement of c e l l  k i l l  by h e a t i n g  nea r  t h e  end o f ,  o r  immediately 
fol lowing,  exposure t o  X-radiation. 
Sapare ta  -- e t  a l .1976 ( r e f .  15) compared t h e  e f f e c t  of hea t ing  ( 4 2 . 5 ' ~  o r  
45.5OC) CHO c e l l s  dur ing  and up t o  120 minutes be fo re  o r  a f t e r  a  500 r ad  dose 
of X-radiat ion.  The d a t a  c l e a r l y  showed t h a t  t h e  p o t e n t i a t i n g  e f f e c t  of hea t  
on c e l l  d e a t h  w a s  g r e a t e s t  when t h e  r a d i a t i o n  was de l ive red  e a r l y  dur ing  t h e  
hea t ing  i n t e r v a l .  There was a  r ap id  l o s s  of thermal  e f f e c t  i f  t h e  r a d i a t i o n  
was given a f t e r  t h e  hea t ing .  Using r a d i a t i o n  damage t o  mouse s k i n  a s  t h e  
c r i t e r i a  of response,  F i e l d  -- e t  a l . ( r e f .  16) found t h a t  hea t ing  ( 4 2 ' ~  o r  4 3 ' ~  
f o r  1 hour) a t  i n t e r v a l s  up t o  2 hours be fo re  X-radiation y i e lded  a  s i g n i f i c a n t  
thermal enhancement. The thermal  enhancement was l o s t  r a p i d l y  i f '  t h e  h e a t  was 
given a f t e r  t h e  i r r a d i a t i o n .  
G i l l e t t e  and T h r a l l  i n  1975 ( r e f .  17) found thermal p o t e n t i a t i o n  of X-ray 
damage t o  mouse mammary carcinoma t o  be h i g h e s t  when t h e  h e a t  was app l i ed  
immediately a f t e r  i r r a d i a t i o n .  Based on ex tens ive  c l i n i c a l  experience,  Hol t  
( r e f .  18) concluded t h a t  t h e  TER is  maximum when t h e  hyperthermia was d e l i v e r e d  
be fo re  t h e  i r r a d i a t i o n .  Overgaard and Overgaard ( r e f .  19) using a s o l i d  tumor 
i n  mice f i n d  t h a t  t h e  p o t e n t i a t i n g  e f f e c t  of hyperthermia on t h e  response of 
t h e  tumor t o  X-radiation w a s  independent of t h e  sequence i n  which t h e  t rea tment  
were appl ied  up t o  an  i n t e r v a l  of 24 hours.  
It seems reasonable  t o  assume t h a t  t h e  maximum p o t e n t i a t i o n  of r a d i a t i o n  
damage by hyperthermia would occur when t h e  i n t e r v a l  between t rea tments  was 
sho r t .  I n  t h e  a p p l i c a t i o n  of hyperthermia t o  c l i n i c a l  r a d i a t i o n  oncology, t h e  
sequence w i l l  probably be determined by t h e  t rea tment  l o g i s t i c s  of t h e  depar t -  
ment a t  l e a s t  u n t i l  t h e  b a s i s  of s e l e c t i n g  one sequence over  another  i s  more 
c l e a r l y  ev ident .  The express ion  of thermal damage i s  no t  l i m i t e d  t o  t h e  
p o t e n t i a t i o n  of X-ray responses.  F igure  5 ( r e f .  19) shows t h e  i n t e r a c t i o n  of 
hyperthermia and drugs when temperatures  of 42OC produce very  l a r g e  decreases  
i n  c e l l  s u r v i v a l .  F igure  6 ( r e f .  20) shows t h e  response of popula t ion  of tumor 
c e l l s  which were t r e a t e d  -- i n  v ivo  b u t  assayed i n  v i t r o .  These d a t a  i n d i c a t e  
-- 
t h a t  both -- i n  v ivo  and i n  v i t r o  hyperthermia enhances t h e  e f f e c t i v e n e s s  of 
-- 
t h e s e  c y t o t o x i c  agents .  
There a r e  no d a t a  a v a i l a b l e  a t  t h i s  t ime showing t h e  e f f e c t  of mult idrug 
chemotherapy and hyperthermia. Such s t u d i e s  might y i e l d  va luab le  information.  
Before t h e  p o t e n t i a t i n g  a c t i o n  of hyperthermia can be  exp lo i t ed  as p a r t  
of a t h e r a p e u t i c  regimen, i t  is  necessary  t o  e s t a b l i s h  whether a s i g n i f i c a n t  
t h e r a p e u t i c  r a t i o  can be achieved. 
The t h e r a p e u t i c  r a t i o  i s  e s s e n t i a l l y  a cos t -benef i t  assessment ,  F igure  7 
i l l u s t r a t e s  t h i s  r e l a t i o n s h i p .  It i s  determined by e s t ima t ing  t h e  damage 
done t o  t h e  tumor, i . e . ,  r e g r e s s i o n  i n  s i z e  o r  p a l l i a t i o n  of symptoms compared 
wi th  t h e  damage done t o  t h e  normal t i s s u e s  i n  t h e  i r r a d i a t e d  volume. 
Table 2,  based on t h e  work of Robinson i n  Baltimore ( r e f .  21) shows t h a t  
a l though both t h e  TER f o r  tumor and normal t i s s u e s  i nc rease  wi th  temperature,  
t h e  TER f o r  tumors i nc reases  f a s t e r  than  t h a t  f o r  normal t i s s u e  ( s k i n ) .  This  
observa t ion  i n d i c a t e s  t h a t  a s i g n i f i c a n t  t h e r a p e u t i c  r a t i o  can be achieved. 
There a r e  d a t a  i n d i c a t i n g  t h a t  t h e  d i f f e r e n t i a l  s e n s i t i v i t y  of normal and 
tumor c e l l s  is  absent  a t  h igher  temperatures .  
Radiat ion and t h e  Oxygen Ef fec t  
One of t h e  problems confounding t h e  r a d i o t h e r a p i s t  is  t h e  f a c t  t h a t  
hypoxic c e l l s  have a reduced r a d i o s e n s i t i v i t y .  I f  t h e  r a d i o s e n s i t i v i t y  of 
c e l l s  made seve re ly  hypoxic dur ing  i r r a d i a t i o n  i s  compared w i t h  those  f u l l y  
oxygenated, t h e  s e n s i t i v i t i e s  c h a r a c t e r i s t i c a l l y  d i f f e r  by a f a c t o r  of 
between 2 and 3. This  r a t i o  i s  des igna ted  a s  t h e  oxygen enhancement r a t i o  o r  
t h e  OER. In a number of systems, hypoxic c e l l s  have been shown t o  b e  more 
s e n s i t i v e  t o  thermal  i n j u r y  than a r e  t o x i c  c e l l s .  I n  many systems, there-  
f o r e ,  i t  i s  poss ib l e  t o  demonstrate a s i g n i f i c a n t  reduct ion  i n  OER by hyper- 
thermia. This  f a c t  is  p o t e n t i a l l y  of very g r e a t  s ignif ica(nce,  s i n c e  i t  may 
inc rease  the  chance of c o n t r o l  o r  provide p a l l i a t i o n  of bulky l o c a l  d i s e a s e  
which would o therwise  be  impossible ,  This  is  demonstrated by t a b l e  3 taken 
from a r e p o r t  by Robinson ( r e f .  21).  Other i n v e s t i g a t o r s  ( r e f .  22) have a l s o  
observed an  enhanced TER f o r  hypoxic p o l l s .  
Whole Body Hyperthermia 
About 1913, A. A. S t r auss  used surgery  and hyperthermia t o  t r e a t  carcinoma 
of t h e  rectum and colon,  w i th  e x c e l l e n t  r e s u l t s  ( r e f .  23).  By 1956 he had 
t r e a t e d  250 such p a t i e n t s ,  and long-term follow-up ind ica t ed  r e s u l t s  comparable 
wi th ,  o r  s u p e r i o r  t o ,  any therapy then a v a i l a b l e  ( r e f .  24). 
Pe t t i g rew -- e t  a l , ( r e f s .  25 and 26) t r e a t e d  a number of terminal-s tage cancer  
p a t i e n t s  wi th  total-body hyperthermia (41°C t o  42OC) and occas iona l ly  combined 
t h i s  t rea tment  wi th  chemotherapy. I n  a l l  c a ses  t h e  p a t i e n t s  were no longer  
t r e a t a b l e  by convent ional  t h e r a p e u t i c  moda l i t i e s .  For those  t r e a t e d ,  hyper- 
thermia a lone  produced a s i g n i f i c a n t  r eg re s s ion  i n  sarcomas and i n  tumors of 
t h e  g a s t r o - i n t e s t i n a l  t r a c t .  Breast  and geni to-urinary tumors responded poorly.  
A l l  p a t i e n t s  wi th  pa in  o r  b leeding  experienced p a l l i a t i o n  of t h e s e  symptoms. 
Figure 8 taken from a r epor t  by S to lwi jk  ( r e f .  27) shows t h e  probably range of 
temperatures  t h a t  might be t o l e r a t e d  f o r  whole body hyperthermia. It is  
un l ike ly  t h a t  a temperature i n  excess  of 4 3 ' ~  could b e  t o l e r a t e d  f o r  more than  
a few minutes without  s i g n i f i c a n t  r i s k  of s eve re  damage. Most c l i n i c a l  s e r i e s  
0 have t h e r e f o r e  at tempted t o  achieve  a c o r e  temperature i n  t he  razge of 40 C t o  
42.5'~. 
A s  wi th  any therapy whose mechanism of a c t i o n  is  n o t  w e l l  understood 
t h e r e  a r e  many ques t ions  t h a t  remain t o  be  resolved.  It seems l i k e l y  t h a t  
temperatures  only s l i g h t l y  above t h e  normal phys io log ica l  range may s t i m u l a t e  
tumor growth r a t h e r  than  i n h i b i t  i t .  There a r e  some experimental  d a t a  which 
support  t h i s  p o s s i b i l i t y  ( r e f .  28). There i s  some i n d i r e c t  evidence from 
animal s t u d i e s  t h a t  whole body hyperthermia ( t o  4 0 ' ~  temperature e l e v a t i o n )  
may temporar i ly  suppress  immune mechanisms and perhaps p o t e n t i a t e  m e t a s t a t i c  
spread. F igures  9 and 10 taken from a r e p o r t  by Dickson ( r e f .  12) i l l u s t r a t e  
t h i s  concern. Animals s t u d i e s  ( r e f s .  29 and 30) i n d i c a t e  an increased  r i s k  of 
m e t a s t a t i c  spread wi th  whole body hyperthermia. Evidence f o r  an increased  
r i s k  from l o c a l  hyperthermia has no t  been c l e a r l y  demonstrated. The e f f e c t i v e -  
ness  of l o c a l  compared wi th  t o t a l  body hyperthermia i s  i l l u s t r a t e d  by f i g u r e  11 
taken from a r e p o r t  by Dickson and Muckle ( r e f .  30).  This  may not  be  c r i t i c a l  
cons ide ra t ion  i n  p a l l i a t i v e  therapy f o r  systemic d isease .  
Regional Hyperthermia by Per fus ion  
A number of i n v e s t i g a t o r s  have used hyperthermic per fus ion  of e x t r e m i t i e s  
t o  t r e a t  d i s e a s e  when l o c a l  spread was suspected.  The d a t a  i n  t a b l e  4 from 
a r e p o r t  by S t e h l i n  -- e t  a l .  ( r e f .  31) show t h e  r e s u l t s  of hyperthermia pe r fus ion  
on melanoma l e s i o n s  of t h e  e x t r e m i t i e s .  The d a t a  shows hyperthermia r e s u l t e d  
i n  an increased  inc idence  i n  r eg iona l  c o n t r o l  and p a l l i a t i o n  of d i sease .  
Cava l i e r e  -- e t  a l . ( r e f .  4) r epo r t ed  tumor r eg re s s ion  i n  15 of 22 p a t i e n t s  
t r e a t e d  wi th  heated perfused blood f o r  sarcomas and melanomas of t h e  
ex t r emi t i e s .  I n  t h e  Proceedings of t h e  I n t e r n a t i o n a l  Symposium pn Cancer 
Therapy by Hyperthermia and Radia t ion ,  Caval ie re  -- e t  a l ,  ( r e f .  32) reviewed 
t h e i r  experience i n  us ing  hyperthermic pe r fus ion  t o  t r e a t  111 p a t i e n t s  w i t h  
advanced tumors of t h e  ex t r emi t i e s :  5 ,  squamous-cell carcinoma; 27, os teogenic  
sarcoma; 28, o t h e r  sarcomas; and 51, melanoma. I n  some i n s t a n c e s ,  chemothera- 
p e u t i c  agents  were incorpora ted  i n t o  t h e  pe r fusa t e .  Most of t h e s e  p a t i e n t s  
subsequent ly underwent amputation of t h e  a f f e c t e d  limb. ~ l t h o u g h  t h e r e  w a s  a  
v a r i e t y  of temperatures ,  du ra t ions ,  and o t h e r  cond i t i ons ,  t h e r e  was no doubt 
t h a t  i n i t i a l  tumor response and NED s u r v i v a l  f o r  comparable s t a g e s  of c l i n i c a l  
d i s e a s e  t r e a t e d  without  hyperthermia ( h i s t o r i c a l  c o n t r o l s )  were c o n s i s t e n t l y  
improved by t h e  use of hyperthermia. 
H a l l  -- e t  a l , ( r e f .  33) perfused t h e  b ladders  of 32 p a t i e n t s  s u f f e r i n g  fromo 
carcinomas of t h e  u r i n a r y  b ladder  w i th  s o l u t i o n s  a t  temperatures  between 41,5 
and 45 '~.  There w a s  s u b s t a n t i a l  tumor r eg re s s ion  i n  26 of t h e  p a t i e n t s  and 
complete tumor r e g r e s s i o n  i n  4. 
Cockett  -- e t  a 1  ( r e f .  34) r epo r t ed  a  r educ t ion  i n  tumor s i z e  fol lowing l o c a l  
hyperthermia and r e g i o n a l  rad io therapy  i n  7 e l d e r l y  p a t i e n t s  wi th  incu rab le  
carcinomas of t h e  b ladder .  I n  c o n t r a s t ,  Lunglmayr -- e t  a 1  ( r e f .  35) r epo r t ed  
t h a t  l o c a l  hyperthermia combined w i t h  chemotherapy f a i l e d  t o  o f f e r  any sub- 
s t a n t i a l  ga in  i n  t h e  t rea tment  of low s t a g e  v e s i c l e  papillomas because of a  
high r a t e  of complicat ions which followed t h i s  t rea tmect .  
Local Hyperthermia 
Selawry e t  a l , ( r e f .  3) made r e fe rence  t o  more than  30 publ ished c l i n i c a l  
s e r i e s  i n  which a  wide spectrum of tumors were t r e a t e d  by va r ious  combinations 
of X-ray and hyperthermia. A l l  t h e s e  r e p o r t s  noted t h e  p o t e n t i a t i n g  e f f e c t  of 
hyperthermia on r a d i a t i o n  response of t h e  tumor, a l though u n c e r t a i n t i e s  i n  
r a d i a t i o n  dosimetry and temperatures  measurements made more p r e c i s e  comparisons 
of response i m p r a c t i c a l  . 
Hol t  ( r e f .  18) t r e a t e d  p a t i e n t s  by means of a  device  c o n s i s t i n g  of 12 RF 
gene ra to r s  ope ra t ing  a t  433.92 MHz and placed i n  a  c i r c u l a r  con f igu ra t ion ,  
wi th  t h e  p a t i e n t  s i t t i n g  o r  s tanding  i n  t h e  c e n t e r  of t h e  c y l i n d r i c a l  a r r ay .  
For most p a t i e n t s  t h e  RF i r r a d i a t i o n  was combined wi th  X-ray therapy  o r  
chemotherapy. The r e p o r t  i n d i c a t e d  t h a t  363 p a t i e n t s  wi th  advanced d i s e a s e  
were t r e a t e d ,  The au thor  gave no d e t a i l s  concerning t i s s u e  temperatures ,  
du ra t ion  of t h e  radiofrequency t r ea tmen t s ,  o r  i n t e r v a l s  between RF and X-ray 
t rea tments  (H + Rx). He concluded t h a t  RF r a d i a t i o n  produced s i g n i f i c a n t  
enhancement of t h e r a p e u t i c  r a t i o  f o r  p a t i e n t s  r ece iv ing  X-ray therapy.  Hornback 
e t  a l ,  ( r e f ,  36) us ing  a  s i m i l a r  technique  r epor t ed  a  s i g n i f i c a n t  enhancement of 
--
r a d i a t i o n  response f o r  p a t i e n t s  w i t h  a  wide range of malignancies .  
Brenner ( r e f .  37) combined hot  a i r  j e t s  and microwave (2450 mc/sec) t o  
iqduce l o c a l  hyperthermia which they  used wi th  or thovol tage  r a d i a t i o n  t o  achieve  
impressive tumor r eg re s s ion  i n  6 p a t i e n t s .  LeVeen ( r e f .  38) repor ted  a  s e r i e s  
of 21 p a t i e n t s  t r e a t e d  by inducing l o c a l  hyperthermia i n  tumors through use  of 
a  r a d i o  frequency genera tor  opera ted  a t  13.56 MHz. I n  a l l  ca ses  t h e r e  was 
s i g n i f i c a n t  tumor regress ion .  
Johnson (ref, 39) reported results of a pilot clinical trial to assess 
the therapeutic ratio when X-radiation was combined with local hyperthermia to 
treat patients with multiple superficial lesions, i.e., up to 2 cm. in depth. 
The lesions were heated to 41°C to 42.5'~ with 915 MHz microwaves for periods 
of 1% to 2 hours. Heating alone produced no damage to the normal skin. The 
thermal enhancement ratio (TER) for irradiated normal skin was 1.2 to 1.3. 
Heating during and immediately after irradiation produced the maximum response 
of tumor and normal tissues. The data are not yet sufficiently complete to 
make possible an estimate of the therapeutic ratio. 
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TABLE 1. 
39. CP - 41' 0' c 
potential 
41.5 - 43.0'~ 
Differential 
43.5 - 4 6 . 0 ~ ~  
mss of diff- 
Sthulation Thermal damage erential for 
to tuanar cells -damage 
totunnaelLs 
Table - 1 shows the probable useful  range of temperatures for  tumor sens i t izat ion 
i n  therapeutic oncology. 
TABLE 2. 
TEMP. SKIN RESPONSE TUMOR RESPONSE TUMOR T.E.R. 
("C) T.E.D.so.I. T.E.R." T.C.D.sov0 T.E.R." SKIN T.E.R. 
(rads) (rads) 
37.5 2522 1 .OO 5250 1 .OO 1 .OO 
A comparison of the thermally induced increase in radiation sensitivity of C3H mammary 
tumors and normal mouse skin. T.E.R. (Thermal Enhancement Ratio) is defined here as the ratio 
of the dose required to produce 50 percent response at 37.S°C to the dose required to elicit 
the same response at a specified elevated temperature. 
TABLE 3. 
TEMP ANOXIC OXYGENATED O.E.R. 
("C) 
37.5 0.385 + .022 0.947 + .046 2.46 r .18 
41 .O 0.406 + .017 1 .I6 + .09 2.86 2 .25 
42.0 0.68 + .06 1.86 + .017 2.72 r .35 
42.5 1.07 + .06 1.81 + .18 1.69 t .14 
43.0 1.93 + .09 2.66 + .12 1.38 r .09 
43.5 2.24 + . I  7 2.09 + .33 0.87 r .16 
The differential effect of hyperthermia on anoxic and oxygenated mouse bone marrow cells. The 
main body of the table gives slopes of both anoxic and well-oxygenated cells in units of 1 ~ - ~ : r a d .  
Treatment times were for one hour except for the highest treatment temperature. 43.5%. for which a 
shorter time of 20 minutes was used. The O.E.R. values were calculated from the ratio of survival 
curve slopes. 
TABLE 4 .  
COMPARATIVE DATA O N  STAGE IIIA 
METASTATIC MELANOMA O F  T H E  EXTREMITIES 
No Iieat Heat 
(1951-65) (1957-74) 
Number of patients.. . . .  27 30 
. . . . . . . . . . . . .  Female 13 24 
Male . . . . . . . . . . . . . . .  14 6 
Extremity involved 
. . . . . . . . . . . . .  Upper. 7 2 
Lower. . . . . . . . . . . . . .  20 28 
Regional nodes proved 
negative 
microscopically. . . . . .  22/27, 81 % 17/30, 56% 
Patients with more than 
one recurrent (meta- 
. . . . . . .  static) nodule. 21,78% 23,77% 
Radical amputation. . . .  8/27, 30% 0 
Patients perfused . . . . . . .  2 1 /27, 78 % 30/30, 100% 
. . . . . . .  Perfusion drug. .  Alkeran Alkeran 
Average dose 
. . . .  Lower extremity, 1.2-1.6 mgm./kqm. 0.9 mgm./kgm. 
Perfusion time.. . . . . . . .  45-120 mins. 45-120 mins. 
Skin temperature. . . . . .  86-90°F. 102-105°F. 
Muscle temperature. . . .  92-9S°F. 102-104°F. 
Five year survival rate 
Males and females.. .. 22.2%* 76.7%t 
Females only. . . . . . . .  13, 30.7 yo* 24, 88.7%1 
'Crude. 
tBerkson-Gage. 
Figure  1. 
HYPERTHERMIA. man o 1 4 5 ~ ~  
DOSE, r o d s  
Fract.iona1 survival (corrected for cellular multiplicity) of cells heated for various times 
at 46°C (upper curve, @) or X rays (lower curve, m). In this and the following figures curves 
were fitted to the data points by eye. Standard errors were smaller than the plotted points. 
Figure  2. 
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Figure 3. 
The percentage of surviving melanoma cells and fetal melano- 
" 
as a function of the duration of exposure to 43'(mean t S.O. of pooled HOURS AT 43. 
iments given). Data from Table 1. At 4 and 8 hr, the difference in heat The percentage of surviving colon carcinoma cells and fetal 
ivity barreen leal melanocytes and melanoma cells is statistically Intestinal cells as a function of the duration of exposure to 4 T  (mean 2 S.D. 
icant, p < 0.05 and p < 0.01, respectively. of pooled experiments given). Data from Table 2. At 2 and 4 hr, the dilfemnca 
in heat Mnsitivity between fetal intestinal cells end Colon carcinomb cells is 
statistically significant (p < 0.01). 
Figure  4. 
TIME (h) DOSE BLEOMYCIN (uglml) 
Effect of elevated temperature on the killing of 
V-79 Chinese hamster cells by thio-tepa (1 ). 
Effect of elevated temperature on the killing of 
HA1 Chinese hamster cells by bleomych (6). 
Figure 5. 
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Figure 6. 
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Figure 7. 
Approxlnutr range of Intrml body temperatures 
in man wlth a~oclated rIB8pM8r8 or consequences. 
Figure 8. 
- METASTASES 
Different metabolism 
to primary tumour 
(--Resistance) 
TUMOUR 
Promotion of Inadequate heating 
favourable 'soil' I\ ;,*; do' Resistance to heat 
for cancer growth (acquired or inherent) 
Uncontrolled destruction 
1 
h)rigs 
X-Rays 
Chemicals 
Host-tumor-therapy triad interrelationships 
govern therapeutic outcome. The possible hazards 
involving the host and the tumor when heat con- 
stitutes the treatment are indicated; 'potentiators' of 
heat (broken arrow) are viewed as affecting both 
these components. 
Figure  9. 
RABBIT V X P  SYSTEM 
LOCAL 
hyperthermia 
l mmune METASTASES 
reaction DESTROYED 
stimulated 
TOTAL BODY 
* 
lmmune --, METASTASES 
hyperthermia - reaction 
stimulated 
m 
I 
DEPRESSION STlMU LATION 
Scheme to illustrate the difference in results ob- 
tained in treatment of the VX2 carcinoma by local 
heating and total body heating in terms of postulated 
effects on the host immune system. 
Figure  10. 
Total body hewing 
Weeks 
Regression lines fitted to log tumor volume measurements 
from the 7th week following tumor inoculation. Local hyperthermia to 
the tumor-bearing limb (A), or total-body hyperthermia (B), was 
applied on Days 35, 36, and 37 after cell inoculation. The individual 
tumor volumes for all experiments shown in Chart 3 have been plotted, 
and the equation to the regression line in each case is given. 
F igure 11. 
Questions an'd Answers Following Baker's Paper 
Singh: Why d i d  you not  go beyond 43O C? 
Baker: That l a s t  study was not  my p a r t i c u l a r  study; bu t  t h e  reason f o r  n o t  
0 going beyond 43 C is t h a t  a s  you s t a r t  t o  increase  the  temperature i n  
0 
excess of 43 C,  you begin t o  g e t  c e l l  k i l l i n g  and you l o s e  t h e  s e n s i t i z i n g  
e f f e c t  of  t h e  r ad ia t ion .  The idea  of t h e  r a d i a t i o n  i s  t o  increase  the  max- 
imum p o t e n t i a l  very quickly.  A t  higher temperatures you do not  need radia-  
t i o n ;  you k i l l  a l l  the  c e l l s  without  it. 
Merz: What were t h e  drugs? 
Baker: The drugs were cyclophosphamide and adriamycin. 
Merz: What were t h e  two before? 
Baker: The two before  were bleomycin and thio-tepa.  
Singh: D r .  Baker, how i s  the  heat ing  done i n  t h e  s t u d i e s  by D r .  Holt ,  f o r  
example? 
Baker: D r .  Holt uses  a c i r c u l a r  a r r a y  of some 12 radio-frequency genera tors  
opera t ing  a t  414 megahertz. This r a d i o  frequency w i l l  hea t  a very lq rge  
volume of t i s s u e .  The frequency i s  r e a d i l y  absorbed so  t h a t  t h e r e  i s  very 
e f f e c t i v e  heat ing.  D r .  Pet t igrew uses  a l i q u i d  molten p a r a f f i n  ba th .  H e  
bags t h e  p a t i e n t  i n  a p l a s t i c  bag, in tuba tes  him, and uses sp ina l  anesthe- 
s i a .  He depends on t h e  h e a t  of fus ion of t h e  p a r a f f i n  a s  it goes from t h e  
l i q u i d  t o  the  s o l i d  s t a t e ,  i n  o rde r  t o  produce t h e  proper temperature t o  
h e a t  t h e  p a t i e n t .  H i s  p a t i e n t s  a r e  kep t  under these  condi t ions  f o r  6 t o  14 
hours, so it is a simple system. The German group uses  in f ra red  r a d i a t i o n  
f o r  t h e i r  t o t a l  body hyperthermia. The group i n  Colombia a t  Bogota uses 
Coley's tox in ,  o r  i t s  l o c a l  equivalent ,  f o r  inducing systemic hyperthermia. 
Other groups use d i f f e r e n t  frequencies of r a d i a t i o n  f o r  l o c a l  hyperthermia. 
The RTOG protocol  c a l l s  f o r  the  use  of 915 megahertz. W e  have t r i e d  both 
2450 megahertz, and more recen t ly  27 megahertz, r a d i a t i o n  f o r  inducing 
l o c a l  hyperthermia. 
E. Long: I d i d  n o t  ca tch ,  and perhaps you had it t h e r e ,  t h e  amount of time 
t h a t  l o c a l l y  it was heated,  o r  sys temical ly  it was heated,  ve r sus  t h e  
amount of time f o r  t h e  X-ray rad ia t ion .  
Baker: It t u r n s  o u t  t h a t  a s  long a s  you a r e  i n  a temperature range between 
0 0 41 C and 43 C t h e  e f fec t iveness  of  your thermal enhancement -- o r  i f  you 
l i k e ,  the thermal enhancement r a t i o  -- i s  d i r e c t l y  r e l a t e d  t o  the  dura t ion .  
0 So you would, i f  you have a 41 C hyperthermia, l i k e  t o  s u s t a i n  it f o r  a s  
long a s  you could. In  t h i s  circumstance w e  a r e  t a l k i n g  about some 3 ,  4,  5,  
o r  more hours. On t h e  o the r  hand, i f  you can g e t  t o  a temperature of 
0 
around 43 C,  then probably 1 t o  2 hours w i l l  g ive  you t h e  maximum 
the rapeu t i c  r a t i o .  
E. Long: How does t h a t  compare-to t h e  length  of time f o r  t h e  X-rays? 
Baker: W e l l ,  t h e  X-rays a r e  conventionally de l ivered  a t  conventional dose 
r a t e s  of  perhaps 100 t o  250 rads  per  minute. I f  your f r a c t i o n  s i z e  is  a s  
we have usual ly  used, somewhere between 300 and 500 rads  per  f r a c t i o n ,  then 
t h e  dura t ion  of your r a d i a t i o n  would be somewhere between 3 and 5 m i n u t e s .  
Yes, D r .  Atkinson. 
Atkinson: Don, when I came i n ,  you had a s l i d e  up of  the rapeu t i c  r a t i o s ;  
and I d i d  n o t  q u i t e  g e t  t h e  s t o r y  t h a t  went wi th  them. Was t h a t  on i n  
v i t r o  o r  i n  vivo measurements? How was it measured? 
Baker: I a m  no t  sure  which s l i d e  we were t a l k i n g  about. I th ink t h i s  was 
an i n  vivo mouse mammary carcinoma system. 
Atkinson: How was t h e  damage t o  t h e  normal t i s s u e  measured? 
Baker: I understand, yes. This was t h e  damage done t o  t h e  skin .  This was 
a sk in  r e a c t i o n  graded 1, 2, 3, e t c . ,  compared t o  l o c a l  con t ro l  of t h e  mam- 
mary tumor. This was t h e  r a t i o .  
Singh: The temperatures t h a t  you a r e  t a l k i n g  about a r e  the  e n t i r e  mouse 
temperatures. They a r e  n o t  t h e  temperatures of t h e  regisi i  you a r e  t r e a t i n g .  
Is t h a t  r i g h t ?  
Baker: Well, i n  some of t h e  work I was r e f e r r i n g  t o ,  we were t a l k i n g  about 
systemic hyperthermia and t h e  temperature of t h e  whole body. I n  o the r  
cases ,  it was l o c a l  hyperthermia and t h e  temperature of t h e  tumor, o r  t h e  
volume t h a t  you a r e  p a r t i c u l a r l y  concerned with r ad ia t ing .  
Singh: And t h a t  was t h a t  low f o r  t h i s  t reatment? It d i d  no t  go higher? 
Baker: No, no. Once you g e t  higher than about 43O C ,  you begin t o  produce 
such an inc rease  i n  s e n s i t i v i t y  of t h e  normal t i s s u e s  t h a t  your therapeut ic  
r a t i o  i s  l o s t  and the re  i s  no advantage. 
Beebe: I n  these ,  d id  you measure t h e  temperature of t h e  tumor and of t h e  
t i s s u e  separa te ly?  
Baker: Y e s .  That is the  way t h a t  we always t r y  t o  do it. There a r e  some 
considerable d i f f i c u l t i e s  with making t h a t  measurement, a s  you can well  
imagine,because the re  a r e  l o c a l  a r e a s  where t h e r e  i s  c i r c u l a t i o n ,  and f o r  
o the r  t echn ica l  reasons and physio logica l  reasons,  t h e r e  a r e  temperature 
g rad ien t s  t h a t  e x i s t .  
Rosato: D r .  Baker, t h e  incidence of  cancer i n  undescended t e s t e s  i s  known 
t o  be seven- o r  e ight - fo ld  g r e a t e r  than the  normal s i t u a t i o n .  The assump- 
t i o n  unproven i s  t h a t  t h i s  i s  t h e  r e s u l t  of t h e  exposure of t h e  t e s t i c l e  t o  
a higher temperature over a longer per iod  o f  time i n  i t s  intra-abdominal 
posi t ion.  Is there any l i t e r a t u r e ,  o r  any caveats, about the  possible 
carcinogenic e f f e c t  of hyperthermia, especial ly  when applied over a long 
period of time? 
Baker: No .  This is information we do not have, but  there  a r e  a couple of 
s tud ies  i n  which t h i s  i s  addressed ind i rec t ly .  I f  you take.an animal, a 
r a t  fo r  example, and place him i n  a chronic, low temperature, 3 o r  4 
degrees above freezing,  he compensates f o r  t h i s  by increasing h i s  metabolic 
r a t e .  In  f a c t ,  he w i l l  double it. He w i l l  l i v e  h i s  whole l i f e  a t  twice 
i t s  normal r a t e .  Not only t h a t ,  but he w i l l  compensate by increasing h i s  
core body temperature. H i s  core body temperature w i l l  go up about 2 
degrees, so now you have an animal whose core temperature i s  up 2 degrees, 
and it i s  up 2 degrees f o r  the  r e s t  of h i s  l i f e .  Now, the  incidence of 
tumors i n  those animals i s  dramatically l e s s ,  not more, so  t h a t  t h i s  Leaves 
the  question s t i l l  very much unanswered. But t h a t  i s  about the  only com- 
parison I can make f o r  you. 
CURRENT STATUS OF WHOLE BODY HYPERTHERMIA TECHNOLOGY 
E. RONALD ATKINSON 
ABSTRACT 
Various techniques for  the c l in ica l  practice of whole body 
hyperthermia (WBH) have been reported over the past 60 years. These 
techniques have involved the use of assorted exotic instrumental para- 
phenal i a  which had made WBH cumbersome and dangerous to  apply. Recently, 
new insights into the production and control of WBH have been obtained 
a t  the Division of Cancer Treatment of the National Cancer Ins t i tu te .  As a 
resu l t ,  WBH technolgoy has been vastly simplified t o  the point tha t  current 
c l inical  t r i a l s  a t  NCI demonstrate tha t  WBH may now be safely performed a t  
nominal whole body temperatures of 4Z°C, routinely, for  four-hour periods. 
Using these techniques, patients have been and are  being treated in a wide 
variety of disease s ta tes .  I t  has become apparent tha t  WBH, so performed, 
i s  simple enough t o  be applied by one or two paramedical personnel, as a 
bedside procedure, under the supervision of a physician. No elaborate 
equipment i s  required and the conditions of treatment are controlled and 
reproducible. Of great importance to  the radiotherapy community, the 
patient,  during t h i s  WBH, i s  accessible for  adjuvant therapy and i s  f ree  
t o  be transported from place t o  place without support equipment. 
If  i t  may be assumed that  4Z°C i s  an effect ive radiosensitization 
temperature, i t  i s  apparent that  we have, already a t  hand, a safe ,  simple 
and effect ive means t o  i r rad ia te  deep internal organs a t  t h i s  elevated 
temperature. In addition, mild WBH, a t  about 3g°C, produced by these 
modern techniques, has been found to  l inearize and increase patient response 
t o  external heat sources to  the extent tha t  techniques of local hyperthermia 
may be greatly simplified. 
A1 though 1 imited data are available on the e f fec t  of 41°c local hyper- 
thermia on tumor PO2,  no data are  currently available on the e f fec t  of 
whole body hyperthermia on tumor blood flow, pH, PO2 and oxygen response. 
This physiological data should be determined t o  allow predictions t o  be 
made of future c l in ica l  t r i a l s  on the basis of col la teral  hyperthermia 
investigations. 

TEMPERATURE UNIFORMITY IN HYPERTHERMAL TUNOR THEWY* 
George H. Harrison, J. Eugene Robinson, and George M. Samaras 
University of Maryland School of Medicine 
SUMMARY 
C3H mouse mammary tumors heated by water bath or by microwave-induced 
hyperthermia exhibit a response that varies sharply with treatment temperature; 
thereforep uniform heating of the tumor is essential to quantitate the biolog- 
ical response as a function of temperature. C3H tumors implanted on the mouse 
flank were easily heated to uniformities within 0-10 C by using water baths. 
Cold spots up to lo C below the desired treatment temperature were observed 
in the same tumors implanted on the hind leg. These cold spots were attributed 
to cooling by major blood vessels near the tumor. In this case temperature 
uniformity was achieved by the deposition of 2450 MHz microwave energy into 
the tumor volume by using parallel-opposed applicators. 
INTRODUCTION 
Our group has carried out a series of hyperthermia studies by using third- 
generation transplants of spontaneous mammary tumors on the flanks of C3H mice. 
The tumors were heated by immersion in water baths and considerable effort was 
expended to characterize tumor thermal uniformity under treatment conditions 
(ref 1 The results indicate that the tumors were uniform in temperature 
to within about O.1° C and were within about O.1° C of the core of the water 
bath. 
Data taken with this tumor and water bath heating showed (fig. 1) a dra- 
matic effect of hyperthermal treatment on tumor radiosensitivity (ref. 2). The 
increase in radiosensitivity was a strong function of treatment temperature. 
In addition, a comparison of these tumor data with comparable data from normal 
mouse skin showed that a therapeutic advantage might be gained by ionizing 
radiation treatment at elevated temperatures (ref, 2). Data from other labora- 
tories, primarily from tumors implanted on the mouse leg and also heated by 
immersion in water baths (ref- 3), show smaller therapeutic advantages for 
similar water bath temperatures and X-ray doses. In addition, heat alone 
provides a therapeutic advantage, treatment sensitivity depending strongly 
on temperature . 
HEATING METHODS 
To broaden our heating capability we have developed microwave heating 
techniques applicable to small laboratory animals, (See refs. 4 and 5,) 
*Supported in part by ACS Grant PDT-33 and USPHS NIH Graf~t CA 18872-01. 
One of our approaches has been to surround the mouse tumor with solid or liquid 
bolus material in plane-parallel-slab geometry and to irradiate with parallel- 
opposed microwave beams, in direct analogy to conventional radiation therapy 
techniques used with ionizing radiation. Microwaves at 2450 MHz are delivered 
by simulated TEM waveguide applicators, time multiplexed so that tumor heating 
occurs from opposite sides (fig. 2). By using the semi-solid Guy-type muscle 
phantom material as bolus (ref. 6), tumor heating nonuniformities were at 
least 0.3O C. 
One difficulty is that there are unavoidable temperature gradients from 
surface to interior in solid bolus material. In a stirred heated liquid bolus, 
these gradients would be negligible. The liquid also improves thermal coupling 
between bolus and tumor. Therefore, we are currently using a heated solution 
consisting of 80% (w/w) isotonic and saline and 20% (w/w) ethanol. Electric 
properties of this solution closely approximate those of wet tissues at 2450 MHz. 
Even when unstirred, substitution of the liquid bolus has resulted in substan- 
tially improved tumor heating uniformity and a significant reduction in thermal 
inertia. Faster liquid heat-up may be due to the realization of a more favor- 
able bolus coupling geometry rather than to calorimetric properties of the 
solution, although the liquid phase promotes convective. heat transfer between 
tissue and phantom. The bolus material is maintained at a temperature slightly 
lower than the desired tumor treatment temperature, and microwave energy sup- 
plies the additional required increment in heating. 
TUMOR TEMPERATURE PROFILES 
The parallel-opposed microwave heating apparatus has been used to treat 
tumors implanted on the flank and on the leg. Temperature distributions 
were measured by drawing small thermistor probes (YSI 514, 524) through the 
tumor, along parallel lines at different distances from the bone and leg muscle. 
As in the case of water bath heating, uniform temperature distributions were 
achieved for the flank tumors, that is, constant temperature to within 50. lo C p  
without the introduction of microwave power. In contrast, immersed leg tumors 
were quite nonuniform in temperature in the absence of microwave power. Fig- 
ure 3 shows two thermal profiles taken through a leg tumor. The tumor was 
roughly ellipsoidal in shape and measured 15 x 12 x 8.5 mm along the three 
orthogonal major axes. The water bath in which it was immersed was maintained 
at 42.g0 C. One profile was taken along a line near the leg bone, but well 
within the tumor. The second was taken about one-third of the way into the 
tumor on the side away from the bone. The profile shows marked temperature 
variations with temperatures measured as low as 41.6O and 42.2O C for the 
thermal scans near and away from the bone. 
Figure 4 gives another example of the cold central region near the bone 
of a smaller tumor (10 x 8 x 5 mm) also heated by immersion, together with 
the more uniform thermal pattern of tumors immersed in liquid bolus and micro- 
wave heated. The liquid bolus was maintained at 42.90 C and the tumor with 
bolus was irradiated with a microwave power of 22 watts. Heating with com- 
bined microwaves and temperature-controlled liquid bolus much improved the 
thermal uniformity as is shown in the two top curves. 
DISCUSS ION 
Temperature nonuniformity of the tumors heated by water bath can be attrib- 
uted to two factors: Major vessels run down both ventral and dorsal aspects 
of the leg and act as heat pipes to locally cool the tumor. In addition, in 
order to reach the inner aspect of the tumor, heat must be transferred through 
the muscle and bone of the leg. The cooling effect of blood flow near the 
bone is also evident in the lower temperature achieved near the bone when 
the tumor was microwave heated. 
Because of the strong dependence of thermal and radiation sensitivities 
on temperature, the cold spots which we see in these tumors would markedly 
affect any measure of tumor response. In assays such as tumor cure and tumor 
regrowth time, the measured response is probably characteristic of the lowest 
treatment temperature experienced by any significant fraction of the tumor 
under treatment. Thus, these tumors on the leg immersed in water baths at 
45.0° C might more appropriately be compared with uniformly heated tumors 
immersed in water baths lo to 1.5O C lower in temperature. 
These observations might have some bearing on the discrepancies in bio- 
logical hyperthermia data on different tumors subjected to apparently similar 
thermal treatments. They should stand as a reminder that careful thermal 
studies are even more important to thermobiology than g m d  raziation dosimetry 
is to conventional radiobiology. 
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Questions and-Answers Following Harrison's Paper 
Singh: Were these temperature measurements simultaneous with the heating? 
Harrison: These were a l l  from cooling curve measurements. We had very 
poorly characterized E&M f i e l d s ,  and we were using metallic.hypodermic 
thermistor probes with thermistors. In f a c t ,  we did  not dare attempt t o  
make measurements with the microwaves on, so each and every datum point  you 
see i s  an extrapolated temperature point  from a cooling curve. 
Carr: When you showed the  apparatus on one of your s l i de s ,  you showed t h a t  
you were using two microwave sources simultaneously? 
Harrison: NO, not simultaneously. They switch back and for th .  We have a 
timing c i r cu i t .  We switch back and fo r th  about avery few seconds o r  so. 
Baker: What was the  composition of your so l id ,  o r  semi-solid, bolus t h a t  
you used? 
Harrison: I cannot remember. It i s  the  one t h a t  Guy uses t h a t  has poly- 
ethylene, powder, and water, o r  s a l i ne ,  I guess. 
THE EFFECT OF HYPERTHERMIA ON THE RADIATION RESPONSE 
OF CRYPT CELLS IN MOUSE JEJUNUM 
John D. Wilson 
Medical College of Virginia 
SUMMARY 
The effect of hyperthermia and/or gamma-radiation on the survival of 
intestinal crypt cells was studied in BDF mice using a microcolony assay. 1 Hyperthermia treatments, which in themselves caused no detectable cell 
lethality, inhibited the capacity of crypt cells to repair sublethal radia- 
tion damage. In addition, heat applied either before or after single radia- 
tion exposures potentiated lethal damage to crypt cells; the degree of en- 
hancement was dependent on the time interval between treatments. At the 
levels of heating employed, DNA synthesis in the intestinal epithelium was 
significantly reduced immediately following exposure, but returned rapidly 
to normal levels. No further disturbances in cellular kinetics were observed 
for up to 10 days after heating. 
INTRODUCTION 
Current investigations into the use of local hyperthermia in the treat- 
ment of cancer can be divided into two basic approaches. In one, the applica- 
tion of relatively high temperatures (generally well above the thermal tolerance 
of normal tissues) is used to bring about the thermal death of malignant cells. 
Experimental evidence indicating that hypoxic cells may be differentially 
sensitive to thermal killing (refs. 1 and 2) makes this approach attractive 
since it has been suggested that radioresistant hypoxic tumor cells may be an 
important factor in cases where conventional radiation therapy fails to produce 
local control. However, recent reports (ref. 3) indicate that in some cases 
cells may also be protected against heat by hypoxia. In addition, significant 
technical problems remain to be solved in confining heat to the tumor volume 
and in accurately monitoring temperatures in normal and tumor tissues in order 
to achieve a favorable therapeutic index under clinical conditions. The second 
approach is to utilize lower temperatures which in themselves do not cause cell 
death, but when combined with conventional treatment modalities, for example 
radiation or chemotherapeutic agents,increase their effectiveness. At the 
present time, this approach is technically more feasible in terms of clinical 
application. 
Fractionated radiation therapy alone is effective in the local control of 
many human tumors. The therapeutic advantage in these instances is believed 
to involve differences between normal and tumor tissues with regard to such 
factors as repair of radiation damage, proliferative capability, redistribution 
throughout the cell cycle, and reoxygenation of hypoxic tumor cells. It has 
been cautioned (ref. 4) that if hyperthermia is to improve the local control of 
tumors, the ideal combination should exploit the beneficial effects of heat 
without compromising the factors which are the basis of the existing thera- 
peutic advantage of fractionated radiation therapy. Thus, to achieve this 
goal it is important to determine the effect of hyperthermia on each of these 
processes in normal as well as tumor tissue. 
This paper reports the results of some preliminary experiments on the 
response of normal tissue to combined radiation and hyperthermia treatments. 
Specifically, the effect of hyperthermia on repair of radiation damage and 
the effect of treatment sequence and interval between treatments were studied. 
The crypt stem cell compartment of the mouse intestinal mucosa was chosen as 
the biological test system. This is a cell renewal system of the type that 
is dose limiting for the acute radiation response in clinical situations. 
In addition, crypt stem cells have a sizeable capacity to repair radiation 
damage (refs. 5 and 6) making them ideal for studies on the effect of hyper- 
thermia on repair processes. 
MATERIALS & METHODS 
General 
Adult female BDF mice 8 to 12 weeks old weighing 20 to 22 grams were 
used in all experimenks. Each treatment group consisted of 5 to 8 animals 
selected at random. Groups were caged separately and maintained in controlled 
temperature and lighting conditions throughout the experiments. Food and 
water were available ad libitum. 
For hyperthermia treatments, unanesthetized animals were loosely restrain- 
ed in thin-walled, 30mm x 82mm plastic tubes. The animals were immersed in 
an upright position in an insulated water bath to approximately mid-thorax 
level. The walls of the restraining tubes were perforated with numerous holes 
so that the animals were in direct contact with the water. A commercially 
available constant temperature circulator was used to exchange the bath. BYo 
adjusting the thermostat, heater wattage and flow rate, a variation of f 0.1 C 
from the desired bath temperature could be maintained throughout the treatments. 
In initial experiments, rectal temperatures were monitored during hyperthermia 
exposures using a recording thermistor. 
Unanesthetized animals confined in a cylindrical lucite box received total- 
body gamma-irradiation at room temperature and in room air by using a conventional 
g O ~ o  teletherapy unit. The dose rate was 50 radslmin as determined by a 
Victoreen chamber placed in a mouse phantom positioned in the lucite holder. 
Survival of intestinal crypt cells following radiation and/or heat treat- 
ments was determined by using the microcolony assay of Withers and Elkind (ref. 
Three and one-half days after treatment, animals were killed by cervical dis- 
location. Segments of the jejunum were dissected out and fixed in buffered 
formalin. Histological slides of transverse sec,tions taken at intervals along 
the length of the jejunum were prepared and stained with hematoxylin and eosin. 
Each section was examined microscopically and the number of crypts appearing 
around the circumference of the intestine recorded. Crypt shrvival for a given 
treatment was expressed as the average number of crypts per circumference 
determined from counts of 4 to 5-sections from each of 3 to 8 animals. 
Recovery (Repair) Experiments 
Recovery from radiation damage was measured using the split-dose technique 
of Elkind and Sutton (ref. 8) and utilized by Withers and Elkind (refs. 5 and 6) 
in studies of the radiation repair capacity of intestinal crypt cells. In 
these experiments, animals were given two doses of radiation separated by 
varying intervals of time. Control animals received an equivalent dose as a 
single exposure. To test the effect of heat on repair of radiation damage, 
hyperthermia treatments were initiated as soon as possible (within 3 to 4 min) 
after the end of the first radiation dose. After the hyperthermia treatment, 
animals were returned to their cages at room temperature for various intervals 
before exposure to the second radiation dose. 
Sequence-Interval Experiments 
In experiments to test the effect of the order of hyperthermia and radia- 
tion treatments and the interval between treatments, animals were given an 
initial exposure of either heat or radiation then caged at room temperature 
for varying time intervals prior to the appropriate second treatment. 
Effect of Heat on Stem Cell Kinetics 
In order to examine the effect of hyperthermia treatments on crypt cell 
kinetics, animals were heated and at intervals up to 10 days after treatment, 
groups of 5 or 6 animals were injected intraperitoneally with 25 microcuries 3 
of tritiated thymidine ( H-TdR). Thirty minutes later the animals were killed 
by cervical dislocation. Jejunal segments were then dissected out and imme- 
diately placed in iced, buffered saline. Sections approximately 5 mm in length 
were immediately slit longitudinally, rinsed in saline, blotted, and weighed 
to O.lmg. The sections were then fixed overnight in acetic alcohol (1:3). The 
following day, sections were transferred to scintillation counting vials and 
solubilized at 55'~ for 1 hr. Ten ml of scintillation cocktail were added and 
radioactivity determined in a liquid scintillation counter. Raw data were 
converted to dpm/mg wet weight of jejunum using quench correction data obtained 
from a quenched tritium standard set counted with the gut samples. Within 
certain limitations, these values are directly related to the number of crypt 
cells in the DNA synthetic phase (S-phase) of the cell cycle (ref. 9). 
RESULTS AND DISCUSSION 
Animals placed in the water bath for hyperthermia treatment required several 
minutes before their body temperature reached that of the bath. Figure 1 is a 
typical heating curve recorded from the rectum of an animal placed in a 42.1'~ 
bath. Equilibration was obtained after 8 to 10 min. Once equilibration was 
achieved, it was maintained for the duration of the longest heating periods 
employed (30 min). Comparable results were observed at lower,bath temperatures 
and with thermistors implanted directly in the lumen of the jejunum. A dis- 
advantage of this method of heating is that the thermal tolerance of the 
whole animal is much lower than-in techniques involving smaller heated volumes. 
For example, most of the animals heated for 30 min in a 42'~ bath were moribund 
upon removal from the bath, and a significant proportion (up to one-third) 
died within 3 to 4 hr after exposure. The body temperature of these animals 
dropped rapidly to room temperature after removal from the bath; however, 
survivors regained their homeothermic capability by the following day. It has 
been reported that in mice heated under similar conditions, brain temperature 
may reach that of the bath even though the animal's head is well out of the 
water (ref. 10). Therefore, damage to areas of the hypothalamus responsible 
for integration of temperature control mechanisms may be involved. This post- 
heating response is almost certainly different from that following local heat- 
ing techniques involving proportionately smaller tissue volumes. It must be 
considered as a possible factor in differences that may arise in the response 
of tissues to combination treatment under the two methods of heating. The dose 
response for thermal death as a function of bath temperature must increase 
very rapidly under the essentially whole-body heating conditions employed in 
these experiments since no early deaths were observed in animals heated for 
0 30 min in 41.5 C baths; these animals rapidly regained their normal level of 
activity after heating. 
The effect of hyperthermia on the capacity of crypt stem cells to repair 
radiation damage is shmmin figure 2. The upper curve (circles) indicates the 
amount of recovery that occurred as a function of time between two radiation 
doses of 700 rads each. The crypt recovery factor plotted on the ordinate is 
the ratio of the number of crypts/circumference that survived the split dose (S  ) 
to the number of crypts/circumference that survived a single dose of 1400 rads 2 
(S1). Maximum recovery, amounting to slightly more than a 5-fold increase in 
surviving crypts, occurred within about 4 hours. This split dose response is 
similar to those reported for a variety of biological systems. It is most 
often interpreted as indicating intracellular repair of sublethal damage in- 
flicted by the first radiation dose (ref. 8), although other interpretations 
have been suggested (ref. 11). 
The dashed curve (squares) traces recovery that occurred in animals heated 
0 
at 42 C for 30 min immediately after exposure to 700 rads and then returned to 
room temperature for various times prior to a second 700 rad exposure. The 
maximum amount of recovery in heated animals was about 30% of that seen in 
animals held at room temperature between radiation treatments. No reduction 
in crypts was detected in animals receiving the hyperthermia treatment only. 
In animals receiving the second radiation dose immediately after the heat treat- 
ment, it was consistently observed that crypt survival was lower than in animals 
receiving the equivalent single dose. This resulted in a recovery factor less 
than one (square at one-half hr in fig. 2). This observation will be discussed 
below. 
The effect of the length of the heat treatment on the extent of recovery 
is also shown in figure 2. The triangles show crypt recovery factors for 
animals irradiated with two 700 rad doses separated by 3 hours and treated immedi- 
ately after the first exposure in a 42'~ water bath. The numbers beside each 
symbol indicate the length of heat exposure in minutes. The hyperthermia treat- 
ment had to exceed 10 minutes before appreciable inhibition could be detected. This 
information is replotted in figure 3 as the percent inhibition of 3-hour recovery 
as a function of heating time. After equilibration with the bath, inhibition 
of recovery increased rapidly witE time reaching maximum value of about 60% 
inhibition at 30 min. Similar experiments were done to examine the influence 
of bath temperature on recovery (fig. 4). It is evident that recovery in- 
hibition was highly temperature dependent and decreased from about 60% to less 
than 10% over a range of 2O C. 
Reduced capacity to repair radiation damage after hyperthermia is a con- 
sistent finding in many biological systems. The denaturation of enzymes in- 
volved in the repair of radiation-induced lesions in DNA has been suggested as 
the mechanism involved in thi.5 inhibition (ref. 12). Unrepaired DNA damage 
may subsequently become lethal to the cell. Studies at the molecular level 
involving the effect of heat on repair of specific types of lesions (single 
strand breaks) support this hypothesis (ref. 13). 
, Results of experiments to examine the dependence of crypt survival on the 
sequence of combined hyperthermia-radiation treatments and on the time lapse 
between heat and radiation administration are shown in figure 5. The solid 
lines indicate crypt survival in animals heated at 41.5O~ for 30 min at various 
times before or after a single radiation dose of 1200 rads. Crypt survival in 
animals which received radiation only (1200), heat only (41.50) or neither treat- 
ment (C) is also indicated for reference. (The abscissa does not apply to these 
points.) When the interval between treatments was 2 hr or less, a hyperthermia 
treatment which was itself sublethal significantly enhanced the lethal effect 
of 1200 rads. Enhancement was achieved in both treatment sequences. The extent 
of potentiation was dependent on treatment interval, being greatest for no delay 
between exposures and decaying as the interval between treatments increased. The 
rate of decay of potentiztion was nearly the same for heat applied before or 
after radiation; the loss of potentiation may have occurred at a slightly slower 
rate when heat followed radiation although further experiments must be carried 
out to confirm this. (In figure 5, compare the solid post-heat curve with the 
dashed curve representing the reversed pre-heat curve.) These time-dependent 
patterns of heat-radiation interaction in crypt cells differ from those reported 
for other biological systems. For example, heat potentiation of radiation damage 
in the skin of mice (ref. 14) and in cultured plateau phase mammalian cells (ref. 
15) was found to decay more slowly when heat preceded radiation. In the latter 
case, it was suggested that repair of sublethal heat damage may be slower than 
repair of sublethal radiation damage. However, the mechanism of heat potentiation 
of radiation damage is not known. Although there is extensive evidence that heat 
can affect enzymatic radiation repair mechanisms, less attention has been given to 
the possibility that heat may modify either the radiation target itself or the 
initial radiation-induced lesions (ref. 12). 
Heat potentiation of radiation damage in crypt cells (fig. 5) is probably 
the explanation for the consistent observation of a recovery factor less than 
one in split-dose experiments (fig. 2) in which both radiation doses and the 
intervening heat treatment were all given within a very short interval. In 
these cases, heat enhanced the effect of both the first and second radiation doses 
resulting in a lower level of crypt survival than that seen in animals receiv- 
ing an equivalent single dose of radiation. 
The data in figure 5 a l m  suggest that as the time interval between treat- 
ments increased beyond 2 to 3 hr, heat may have protected crypt cells from 
radiation lethality. Crypt survival values for animals heated 2 and 4 hr before 
and 4 hr after irradiation were higher than for animals receiving radiation 
alone. The differences, however, are marginal and must be substantiated in 
further experiments. 
The fact that the heat treatments employed in these experiments were 
sublethal in terms of crypt survival did not rule out the possibility that 
alterations in crypt stem cell kinetics might occur as a consequence of heat- 
ing. Marked differences in the proliferative activity of the intestinal 
epithelium have been observed following exposure to radiation as well as chemo- 
therapeutic agents (refs. 16, 17, 18, 19, and 20). In addition, it has been 
reported that cells in culture can be blocked at specific points in the cell 
cycle as a result of hyperthermia treatment (refs. 21 and 22). It should be 
assumed that such changes in cell kinetics could be important determinants of. 
the response of renewal tissues to combined modality treatments. Thus, prelim- 
inary experiments were carried out to investigate the occurrence of altered 
crypt cell proliferation. Figure 6 shows the 30-min incorporation of 3 ~ - ~ d ~  
into the DNA of intestinal crypt cells of mice heated for 30 min in a 42'~ 
water bath as a function of tine after treatment. Radioactivity (dpm/mg wet 
weight) of jejunal segments from heated animals is presented on the ordinate as a 
ercent of control radioactivity of segments obtained from unheated animals. 
%-TdR incorporation in this type of experiment is a direct measure of S-phase 
cellularity and is assumed to be indicative of the size of the proliferative com- 
partment of the intestinal epithelium (ref. 9). The marked depression in 
3 ~ - T ~ R  incorporation which occurred in crypt cells sampled 1 hr after heating, 
however, was more likely a reflection of decreased DNA synthetic activity 
rather than a reduction in the number of S-phase cells. Recovery from this 
depression was rapid and the radioactivity of samples obtained from animals 
12 hr to 10 days after heating fluctuated within f 10% of control values. 
Therefore, although short-term changes in the rate of DNA synthesis may have 
occurred after the heat exposures employed in the combined modality experi- 
ments reported here, marked long-term alterations in crypt stem cell kinetics 
were not detected. 
The results of these experiments indicate that caution must be exercised 
in clinical situations where it is proposed to use mild heating as an adjunct 
to conventional radiation therapy. If heating of the tumor volume results in 
increased temperatures in surrounding irradiated normal tissues as well, 
radiation damage there may be significantly enhanced and its normal repair 
compromised. An increase in therapeutic advantage thus may not be realized 
in combined hyperthermia-radiation treatment as a consequence of these alter- 
ations in tissue response. 
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A MICROANGIOGRAPHIC STUDY OF THE EFFECT OF HYPERTHERMIA ON THE 
RABBIT BLADDER 
S-0. H i e t a l a ,  R. Howells, and T. A.  Hazra 
Medical College of V i rg in i a  
Hyperthermia i s  now an  accepted mode of t reatment  w i th  r a d i a t i o n  therapy 
and chemotherapy. Its use  has been very  r e s t r i c t e d ,  and a  wider use  w i l l  en- 
counter  t h e  same l i m i t a t i o n  a s  r a d i a t i o n  therapy;  namely, t h e  t o l e r a n c e  l e v e l  
of normal t i s s u e .  
It is t h e r e f o r e  worthwhile t o  d e v i s e  a  model t o  s tudy t h e  e f f e c t  of hy- 
per thermia on a  normal t i s s u e .  The model s e l e c t e d  was t h e  r a b b i t  bladder  and 
t h e  end p o i n t  measured was t h e  changes i n  t h e  micro-vasculature of t h e  blad- 
der  wa l l .  It has  a l r e a d y  been demonstrated c l i n i c a l l y  t h a t  ho t  water bladder  
i n fus ions  w i l l  produce r e g r e s s i o n  i n  b ladder  tumours ( r e f . 1 ) .  
Ma te r i a l  and Method 
New Zealand wh i t e  r a b b i t s  (male) weighing approximately 4 kg were 
c a t h e t e r i z e d  and infused  wi th  s t e r i l e  water  heated t o  4 3 ' ~  + %OC. The water 
was heated i n  a  c o i l  i n  a  hea t ing  b a t h  and t h e  bladder  t e m ~ z r a t u r e  w a s  moni- 
to red  w i t h  a  t he rmis to r  threaded through t h e  c a t h e t e r .  The water  ba th  temp- 
e r a t u r e  was c o n t r o l l e d  by an  au tomat ic  hea t ing  c o i l  and cold water  pump. An 
a t tempt  was made t o  main ta in  s t e r i l i t y  and t h e  animals were anaes the t i zed  w i t h  
p e n t o b a r b i t a l  dur ing  t h e  15 minutes i n f u s i o n  time. 
The animals were kept  f o r  pe r iods  vary ing  from 7 days t o  3 months, when 
microangiography was performed on t h e  animals ( r e f  2) .  
The r a b b i t s  were anaes the t i zed  and t h e  abdomen opened t o  r e v e a l  t h e  ab- 
dominal a o r t a  which was then  c a t h e t e r i z e d ,  and a  7% suspension of micro-opaque 
(barium su lpha te )  in fused  from a h e i g h t  of about  80 cm. 
When t h e  b ladder  v a s c u l a t u r e  was f i l l e d  wi th  c o n t r a s t  medium (about 2  
hours ) ,  t h e  bladder  (which has been d is tended  by f i l l i n g  wi th  water)  was d i s -  
sec ted  o u t  and f i x e d .  
The b ladders  a r e  then  c u t  i n t o  two ha lves  and s t r e t c h e d .  They a r e  then 
s e t  i n  a  t h i n  l a y e r  of p a r a f f i n  and 30 Kvp radiographs taken of them on high 
r e s o l u t i o n  p l a t e s  (Kodak). 
- Measurements 
The normal b ladders  were used a s  a  s tandard  t o  e s t a b l i s h  t h r e e  measure- 
ment c r i t e r i a :  
1. The number of v e s s e l s  c ros s ing  a  1 mm l i n e  i n  t h e  most v a s c u l a r  a r ea .  
2. The width of t h e  v e s s e l s  i n  t h e  same a r e a .  
3 .  The t o r t u o s i t y  of t h e  5 most t o r tuous  v e s s e l s  between two t e rmina l  
p o i n t s  separa ted  by 5 mm . 
It was i n  f a c t  found t h a t  t h e r e  was a c l o s e  c o r r e l a t i o n  between t h e  scor- 
ed r e s u l t s  and a  s imple v i s u a l  assessment based on experience i n  observing 
t h e  samples. 
I t  i s  important  t o  avoid i n f e c t i o n  i n  t h e  bladder  because t h e  appearance 
of t h e  microangiogram of a n  i n f e c t e d  b ladder  can c l o s e l y  resemble t h a t  of a  
bladder  which has  sus t a ined  some o t h e r  i n j u r y  such a s  r a d i a t i o n  damage ( f i g  1). 
Resu l t s  
There i s  no evidence of any immediate change i n  t h e  v a s c u l a t u r e  follow- 
ing  t h e  hyperthermic t rea tment .  However, a f t e r  7 days, t h e r e  was a  n o t i c e a b l e  
slowing down i n  t h e  r a t e  of f i l l i n g  of t h e  v e s s e l s  wi th  micro-opaque, and t h e  
v a s c u l a t u r e  i s  ve ry  s p a r s e  compared wi th  normal samples. 
I n  t h e  case  of t h e  animals  who were kept  f o r  1 t o  3 months pos t  hyper- 
thermic t rea tment ,  t h e  appearance of t h e  b ladders  was perhaps s l i g h t l y  hyper- 
vascu la r  b u t  no t  s e r i o u s l y  abnormal, i n d i c a t i n g  t h a t  t h e  immediate damage was 
r epa i r ed  and t h a t  no medium term damage appears  t o  r e s u l t  from a  s h o r t  hyper- 
thermic t rea tment  a t  a  temperature which i s  s u f f i c i e n t  t o  produce an  enhance- 
ment of t h e  e f f e c t  of r a d i a t i o n  on normal c e l l s .  
A p re sen t  modi f ica t ion  i s  t h a t  t h e  a n a e s t h e t i c  has  been changed t o  sodium 
b r e v i t a l ,  which produces a  s h o r t e r  and shal low anaes the t i zed  s t a t e  and reduces 
t h e  p o s s i b i l i t y  of induced hypothermia, a  cond i t i on  which could poss ib ly  in- 
f l uence  t h e  r e s u l t s .  
F igure  2 shows a  normal bladder  and f i g u r e  3 shows a  s l i g h t l y  hyper- 
vascu la r  pos t  3 months b ladder .  
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Questions and Answers Following Paper by Hie ta la ,  Howells, and Hazra 
D. Cone: What was t h e  composition of t h e  so-called water t h a t  you infused 
with? Was it p l a i n  water ,  d i s t i l l e d  water, o r  what? 
Howells: It was s t e r i l e  water. 
D. Cone: Did it have a  s p e c i f i c  g rav i ty ,  o r  pH con t ro l ,  o r  osmotic control?  
Howells: I t  was p l a i n ,  s t e r i l e  water. 
D.  Cone: Could t h a t  have an e f f e c t ?  
Howells: I do not  know. We were thinking of using s a l i n e ,  b u t  we d id  not .  
We discussed t h i s ,  bu t  we d id  not r,eally think t h a t  it had any s i g n i f i c a n t  
e f f e c t .  

THE COMBINED EFFECTS OF PULSED MAGNETIC RADIATION (DIAPULSE) AND CHEMOTHERAPY 
ON TUMOR BEARING MICE. 
THE MEASUREMENT OF RODENT PALATAL EXPLANTS AS A DEVICE FOR MEASUREMENT OF THE 
BIOLOGIC EFFECTS OF NONIONIC RADIATION (EMR) 
W i l l i a m  Regelson, B r i a n  West, 
Medical  C o l l  ege o f  V i r g i n i a  
and 
Dominick P. DePaola 
F a i r l e i g h  D i ck i nson  U n i v e r s i t y  
SUMMARY 
The aim of this program is  to  study the ef fec t  of nonthermal pulsed 
magnetic radiation on tumor growth and embryoni c devel oprnent. 
Simul tanesus treatment u t i  1 izing pulsed radiowave (diapul se) and cancer 
chemotherapy signif icant ly extended the l i f e  span of BDFl mice w i t h  Lewis 
lung transplanted carcinoma. In comparison w i t h  nontreated controls, the 
combination of hydroxyurea and whole body nonionizing EM radiation ( a t  
27.12 MHz) produced different ial  enhancement of longevity depending on 
power output. The highest power (38 mean watts) had the greatest  effect.  
Hydroxyurea combined w i t h  highest power output achieved by pulsing the 
radiation 600 times per second; a t  a 3.9% duty cycle, peak watts = 975 
produced the mean extension of l i f e  67% greater than tha t  of the group 
treated with hydroxyurea a1 one. 
The s t r e s s  involved i n  confining mice t o  holders and subjecting them 
to both nonionic radiation and chemotherapy produces significant variabi l i ty  
in tumor growth.  To achieve biologic quantification of EMR effects i n  v i t ro  
methods are necessary. We have studied palatal explants from 14 d a y x l d  
mouse embryos suspended i n  t i ssue  cul ture as  the EMR target .  Histologic 
readouts of EMR effects  can be obtained i n  48 hours. This technique is  
d i f f i c u l t  because of problems i n  t i m i n g  mouse pregnancy to  obtain properly 
dated embryos fo r  quanti tation of EMR e f fec ts  of nonionic radiation on' 
ce l lu lar  different iat ion,  migration, adhesion, and destruction. 
The  effect  of EMR on palatal explants and tumor growth can hopefully shed 
l igh t  on the significance of frequency windows vs. temperature effects ,  and 
provide s ignif icant  information relevant t o  the use of nonionic radiation 
in the study of developmental b i r t h  defects as  well as tumor growth. 
INTRODUCTION 
As discussed in our previous papers ( re fs .  1 and 2 ) ,  the evidence sup- 
porting biological ac t iv i ty  on nonionizing radiation based on e i ther  
athermal or relat ively low thermal mechanism needs serious evaluation. 
The diapulse instrument was studied because of i t s  commercial avail-  
ab i l i t y  and unverified reports of c l inical  anti-tumor ac t iv i ty .  
Diapulse has relat ively low thermal e f fec ts  as compared with diathermy 
despite similar reports of c l inical  usefulness in the treatment of injury. 
T h i s  study was prompted by a report by Bassett e t  a l . ,  1974, of inhibition 
of the transplanted METH-A sarcoma in mice by pulsed low energy electromagnetic 
f ie lds  (EMF). This led us t o  study the ef fec ts  of pulsed magnetic radiation 
on tumor growth, normal development and drug metabolism in mice ( re fs .  1 
and 2 ) .  
MATERIALS AND METHODS 
The diapul se instrument operates a t  27.12 MHz car r ie r  frequency. Besides the 
commercial avai 1 abi 1 i ty  of t h i s  source of EMR (F .  D.A. clearance i s  necessary), 
another imnediate advantage was the existence of several f i e ld  analysis studies 
and reports of i ts  cl inical  use and biologic application ( P .  W. Neurath and J. 
L i ,  Personal Communication, 1974 and ref .  3 ) .  
Diapulse's theoretical design i s  based on the concept tha t  pulsed high 
instantaneous power output (on the order of 280 t o  975 watts peak), with rela- 
t ive  low duty cycles (0.15% t o  3.9%, depending on pulse repetit ion r a t e ) ,  should 
permit heat dissipation from t issues during the off-phase (1600 microsecond width 
or  greater).  In addition, the higher peak power levels of this instrument were 
designed t o  be capable, theoret ical ly ,  of inducing t issue ef fec ts  tha t  could not 
be found w i t h  diathermy tolerance because of heat damage. 
The diapulse generator used a fundamental frequency of 6.76 MHz, pro- 
vided by a crystal ,  which i s  doubled and mixed with the output of a multi-vibrator 
stage. Power of the mixed stage i s  amplified, doubled and coupled t o  the 
10 cm treatment head. Pulsed modulation as selected from 80 to  600 cycles per 
second i s  appl ied t o  the amp1 i f ied  stage t o  regulate the radiation supplied 
t o  the treatment head. As maximum set t ings,  the treatment u n i t  supplied 974 
instantaneous watts w i t h  a 3.9% duty cycle, each pulse last ing 65 microseconds. 
This yields a highest average power output of 38 watts. These measurements 
were taken w i t h  a P80 probe placed on the inverted radiation head (1.3 cm re- 
moved from pancake co i l s )  by means of 585A tektronic oscilloscope. 
P. W. Neurath and J. L i  (Influence of pulsed and continuous f i e lds  of a 
diapul se uni t  on peripheral circulation when applied t o  the abdominal region. 
Unpublished manuscript, personal communication w i t h  Medical Device Division, 
F.D.A., 1974), in a study t o  determine the magnetic and electr ical  f i e l d  in- 
tensi t i e s  of a diapul se  instrument, reported similar measurements. A range 
of 10 t o  45 vol ts/cm and a n  approximate 10 gauge fie1 d i s  seen a t  the surface 
of the head. 
TUMOR STUDIES 
Lewis lung carcinoma was obtained i n  the asci tes  form from ser ia l  passage 
in BDFl female mice and injected as a lo6 sal ine cell  suspension subcutaneously 
i n to  the flanks of mice of the same s t r a in  obtained from DBA paternal, C57 
maternal parentage. Details of study are reported in our previous papers 
( refs .  1 and 2) .  
The purpose of t h i s  experiment was four-fold: (1 ) t o  determine the ef fec t  of 
a single drug, hydroxyurea ( H U )  or cytoxan (CTX), upon the tumor; ( 2 )  to  determine 
the effect  of a single drug plus irradiation 160-3 (approximately 4 mean watts) 
(1ow;lo) o r  600-6 (38 mean watts) (high;hi) upon the tumor; (3)  to  determine the 
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ef fec t  of a combination of drugs (HU+CTX) upon the tumor; and (4 )  to  determine 
the e f fec t  of a combination of drugs (HU+CTX) plus i r radiat ion upon the tumor. 
The observed parameter was re la t ive  t o  change in lifespan of experimental 
animals over controls. Eight mice, matched as  t o  age, sex, and weight, were 
treated in each group. 
Chemotherapy 
For more detailed analysis of methodology as re la tes  t o  chemotherapy and 
dose timing of drug administration i n  re lat ion t o  diapulse whole body 
i rradiat ion,  the reader i s  referred t o  our previous publication and our 
Air1 i e  House Conference presentation ( re fs .  1 and 2 ) .  
Palatal Explants 
The palatal processes are  explanted fo l l  owing dissection from timed- 
pregnant Swiss Webster mice a t  day 14 of gestation i n  a 1 :1 !V:V) mixture 
of Tyrode's hose serum. The explants a re  then positioned w i t h  the nasal sur- 
face rest ing on a millipore f i l t e r  (0.3vm) porosity tha t  is  placed in contact 
with a nutrient agar-gel medium consisting of Hank's BME containing 1% agar, 
1% dialyzed fe ta l  calf  serum, and 50 v/ml penicil l  in-streptomycin. All cultures 
were incubated a t  3 7 ' ~  in a humidified atmosphere of 5% C02 in a i r  and harvested 
a t  24 or 48 hours following exposure t o  nonionic radiation. A t  harvest, ex- 
plant cultures were fixed fo r  electron microscopy and fusion was assessed 
according to  the c r i te r ion  of Smiley and Koch, 1971, and DePaola e t  a1 , 1974. 
( re fs .  4 and 5 ) .  Mouse embryos are  dissected a t  14 days gestation and rabbit 
embryos a t  day 16. 
Chemotherapy Results 
There were two baseline controls. The f i r s t  control group who were adminis- 
tered no drugs of any so r t  had an average lifespan of 36.86 days. The second 
group administered sodium pentobarbital to  screen out effects  of anesthesia on 
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experimental groups had an average lifespan of 37.8 days which was not 
significantly different. 
Hydroxyurea Groups 
The group receiving HU alone showed an average lifespan of 45 days with 
an increase of 22.1% over the controls at a significance level of 0.5. The 
group receiving HU plus irradiation at 160-3 (lo) (4 mean watts) showed an 
average lifespan of 38.75 days representing an increase of 5.1% over controls 
at a significance level of 0.75. The group receiving HU plus irradiation at 
600-6 (hi) (38 mean watts) showed an average lifespan of 74.3 days represent- 
ing an increase of 101.9% over controls at a significance level of 0.001. 
Cytoxan Groups 
The group receiving CTX alone showed an average 1 ifespan of 60.5 days 
representing a 64.1% increase over the controls at a significance of 0.05. The 
group receiving CTX plus irradiation at 600-6 showed an average lifespan of 
64.17 days representing a 74.1% increase over controls at a significance level 
of 0.01. The group receiving CTX plus irradiation at 160-3 showed an average 
1 ifespan of 76.14 days representing a 106.6% increase over controls at a 
significance level of 0.005. 
Multiple Drug and Irradiation Groups 
The group receiving a combination of HU and CTX showed an average lifespan 
of 21.67 days representing a 41.2% toxic decrease in lifespan compared with non- 
chemotherapy controls. The group receiving a combination of HU and CTX plus 
irradiation at 160-3 showed an average lifespan of 50.86 days representing a 
38% increase over nonchemotherapy controls and a significance level of 0.01 
from the HU and CTX controls. The group receiving a combination of HU and CTX 
plus irradiation at 600-6 showed an average lifespan of 37.5 days which is an 
increase of only 1.7% over nonchemotherapy controls. 
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The groups i n  order of decreasing importance (experimental groups 
compared w i t h  control groups) : combination CTX and i r rad ia t ion  160-3 showing i n -  
creased 1 ifespan (1,L.S.) of 106.6%; combination HU and i r rad ia t ion  600-6 
showing 1,L.S. of 101.9%; combination of CTX and i r rad ia t ion  600-6 showing 
I.L.S. of 74.1%; CTX alone showing 1,L.S. of 64.1%; combination of H U ,  CTX, 
and i r r ad i a t i on  160-3 showing I.L.S. of 38%; and HU alone showing I.L.S. 
of 22.1% over controls.  The  combination of H U  and CTX without i r r ad i a t i on  
showed a decrease i n  1 ifespan of 41.2%. 
Similar  s tud ies  w i t h  bleomycin given a t  these same radiation power l eve l s  
and pulse frequencies were not s i gn i f i c an t l y  d i f f e r en t  from the nonchemo- 
therapy controls  o r  t h e  bleomycin alone controls ,  
In no case was weight l o s s  a f ac to r ,  nor did pentobarbitol by i t s e l f  
exer t  any therapeut ic  influence on the  r e su l t s  seen. There was no evidence 
of body temperature elevation on assessing rec ta l  and subcutaneous temperature 
by thermistor following power termination i n  a matched BDFl mice group, 
Palatal  Studies 
This program i s  in  prdgress and unfortunately technical problems re la ted  
t o  timing of mouse pregnancy and pala ta l  harvest suggest a t  this time t h a t  a s  
a biological assay of nonionic magnetic radia t ion,  this method of biologic 
assay has var iables  equal t o  t h a t  of tumor growth s tudies  i n  the l iv ing  mouse. 
- DISCUSSION 
In our previous study ( r e f .  1 ) in unanesthetized mice, growth of 
Lewis lung carcinoma tumors were e i t h e r  enhanced o r  inhibi ted depending 
on the  scheduling of the  EMR exposure used. Pre-tumor inoculate 
i r r ad i a t i on ,  one hour daily f o r  one week, resul ted i n  a 49% inhibi t ion i n  
mass a t  post-tumor inoculate day 14 and 45% inhibi t ion a t  day 26 a f t e r  
exposure t o  a 6 mean wat t  (160 pps/585 watts)  power level .  However, extended 
scheduling using dai ly  i r rad ia t ion  f o r  13 pre-and 6 post tumor inoculate 
days, a t  the  same power l eve l ,  resul ted i n  a contrast ing 20% stimulation i n  
tumor growth and the use of higher power levels  was associated with g rea te r  
increased growth of tumors of 54% and 51% (15 mean watts produced by 400 
pps/585 watts and 38 mean watts by 600 pps/975 watts ,  respectively,  given 
f o r  13 pre-and 14 post-tumor inoculation days). In contras t ,  anesthetized 
mice receiving iden t ica l  treatment (1 60 pps/585 watts dai ly  seven pre-and 
s i x  post  tumor inoculate days) demonstrated a greater  inhibi t ion of tumor 
mass, 67%, in comparison w i t h  the  unanesthetized animals, 20%. This may 
indicate  an e f f e c t  of temperature elevation i n  view of our data demonstrating 
heat  retention i n  i r rad ia ted  anesthetized mice ( r e f .  1 ) .  
Simultaneous treatment u t i  1 iz ing pulsed radiowave ( D i  apulse) and cancer 
chemotherapy s ign i f ican t ly  extended the  l i f e  span of BDFl  mice w i t h  Lewis 
lung transplanted carcinoma. In comparison w i t h  nontreated con t ro l s ,  t he  
combination of hydroxyurea and whole body nonionizing EM radia t ion ( a t  
27.12 MHz) produced d i f f e r en t i a l  enhancement of longevity depending on 
power output. The highest  power (35 mean watts)  had the  g rea tes t  e f f ec t .  
Hydroxyurea combined with highest power output achieved by pulsing the 
radiat ion 600 times per second; a t  a 3.9% duty cycle, peak watts of 975 
produced the mean extension of l i f e  67% greater than tha t  of the group 
treated w i t h  hydroxyurea alone. 
The s t r e s s  involved in confining mice to  holders and subjecting them t o  
both nonionic radiation and chemotherapy produces significant var iab i l i ty  
i n  tumor growth. To achieve biologic quantification of EMR ef fec ts ,  -- in v i t ro  
methods are  necessary. We are  now test ing palatal explants from 14 to  16 day 
01 d mouse or  rabbit  embryos suspended i n  t issue culture a s  the EMR target .  
Histologic readouts of EMR effects  can be obtained in 48 hours. This technique 
might enable us t o  quantitate EMR ef fec ts  of nonionic radiation on ce l lu lar  
different iat ion,  migration, adhesion, and destruction. The effect  of EMR on 
palatal explants can shed 1 ight on the significance of frequency windows against 
temperature effects  and can provide s ignif icant  information relevant to the use of 
nonionic radiation in the study of development birth defects as well as tumor 
growth. 
The importance of nonionic low thermal radiation i s  seen in the recent 
IV International Bioelectrophysiology Meeting a t  Woods Hole. Low energy 
nonionic radiation ef fec ts  have been seen to  stimulate bone repair ( re fs .  6 
and 7 and C . A .  L. Bassett, personal communication, 1977), derepress frog 
embryo c e l l s  and convert them t o  f ibroblasts  ( r e f .  8), and produces dendritic 
outpouchings in cultured neuronal c e l l s  ( r e f .  9 )  and control dorsal 
ectoderm migration in spinal cord development ( r e f .  10) .  The energy levels 
for these e f fec ts  are  infinitesmal and unrelated to  heat production and 
evidence by references 11 and 12 and others ( r e f .  8 ,  10 and 13) support 
that t h i s  condition i s  associated with calcium flux ( re fs .  14 to  16) 
and may require frequency windows (specif ic  frequencies) fo r  selected 
effects  to  be seen. Calcium ionophores ( r e f .  8, 10, and 13) can mimic a t  
l eas t  some of the effects  reported for  low energy electromagnetic f i e lds  on 
cel l  physiology. 
In view of frequency window data indicating tha t  low energy pulsed 
EMF can affect  a variety of biologic systems with stimulation of bone 
repair and inhibition of tumor growth, further work remains t o  be done in 
test ing varied frequencies f o r  optimal effect .  T h i s  i s  important i n  view 
of Holt 's ( ref .  17) report of increased survival of head and neck cancer where 
microwave a t  434 MHz combined w i t h  radiotherapy was reported t o  increase 2 
year survival of recurrent head and neck epidermoid cancer. Holt in s i s t s  
that  the frequency of 434 MHz is  c r i t i ca l  f o r  resul ts  seen. 
Our future work will explore frequency window effects  ranging from 8 to  400 
MHz. W i t h  new instrumentation from Bassett 's  group and NASA, we will 
avoid the high energies tha t  produce heat effects  although, as  was seen i n  
the diapulse system u s i n g  a pulsed magnetic f i e l d ,  minimal heat was generated 
in both the -- i n  vivo mouse tumor system and in  t i ssue  culture palatal explants. 
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Questions and Answers Following Regelson's Paper 
Beebe: Did you consider the  e f f e c t  c f  t h e  d iu rna l  cycle  on the  
s u s c e p t i b i l i t y ?  
Regelson: Well, t h a t  i s  obviously a f a c t o r ,  b u t  a l l  our work was done 
during the  day. 
Beebe: Was it done rou t ine ly  i n  the  morning? 
Regelson: Yes. Routinely, our  timing was f ixed so  t h a t  a s  a v a r i a b l e  we 
d id  no t  change it. Once we locked i n ,  we were locked i n .  Inc iden ta l ly ,  
t h e  l i g h t  cycle  i n  the  mouse room was cont ro l led .  
G.M. Samaras, J.E. Robinson, 
A.Y. Cheung, and S,F. Weinmann, 
Department of Therapeut ic  Radiology 
Un ive r s i t y  of Maryland School of Medicine 
Bal t imore,  Maryland 21201 
SUMMARY 
Elevated temperature i n c r e a s e s  t h e  e f f i c a c y  of i on iz ing  r a d i a t i o n  and 
c e r t a i n  chemical agen t s  i n  t h e  t rea tment  of some cancers .  The use  of h e a t  
a s  an ad junc t ive  t h e r a p e u t i c  modal i ty  i n  rad io therapy  can, i n  some cases ,  
y i e l d  a  marked inc rease  i n  r a d i o s e n s i t i v i t y  of malignant  t i s s u e  w i t h  only 
a s l i g h t  change i n  t h e  r a d i o s e n s i t i v i t y  of surrounding normal t i s s u e  ( r e f s .  1 to -  3) - 
I n  c o n t r a s t ,  t h e  u se  of h e a t  with chemotherapeutic agents  i nc reases  a b s o r ~ t i o n  
and chemical r e a c t i v i t y  i n  bo th  malignant  and surrounding normal t i s s u e  ( r e f .  4 ) .  
Probably, t h e  most e f f e c t i v e  means of hea t ing ,  e s p e c i a l l y  i n  t h e  c a s e  of deep 
tumors of t h e  head, neck,  abdomen, and l imbs,  w i l l  b e  t o  focus  t h e  temperature 
e l e v a t i o n  i n  t h e  reg ion  of t h e  tumor volume. A s  an ad junct  t o  rad io therapy ,  
t h i s  procedure w i l l  l i m i t  t h e  thermal l oad  and any inc rease  i n  r a d i o s e n s i t i v i t y  
i n  t h e  surrounding normal t i s s u e .  A s  an ad junct  t c  chemotherapy, i t  should 
inc rease  absorp t ion  and chemical r e a c t i v i t y  i n  t h e  tumor volume - t hus ,  a 
means of "s teer ing"  sys temic  drugs t o  d e s i r e d  t a r g e t  sites. 
I n  o r d e r  t o  o b t a i n  focussed microwave h e a t i n g  a t  depth,  we have borrowed 
from t h e r a p e u t i c  rad io logy  t h e  concept of suge rpos i t i on  of s e p a r a t e  r a d i a t i o n  
beams ( r e f .  5) . The a p p l i c a t i o n  of t h i s  multiple-beam paradigm t o  microwave 
diathermy o f f e r s  t h e  p o t e n t i a l  of genera t ion  and c o n t r o l  of spat io- temporal ly  
complex thermal. f i e l d s  deep w i t h i n  t h e  body. Our pro to type  system cons i s t ed  
of two paral le l-opposed s imula ted  TEM a p p l i c a t o r s  ope ra t ing  a t  2450 MHz w i t h  
power time-multiplexed e i t h e r  between t h e  t rea tment  beams o r  o f f  t o  an air- 
cooled load  ( r e f .  6 ) .  Our cu r r en t  system i s  programmable (microprocessor 
c o n t r o l l e d ) ,  capable of suppor t ing  16 min ia tu re  a p p l i c a t o r s ( r e f .  7) and con- 
t r o l l i n g  t h e  output  power of each a p p l i c a t o r ,  wh i l e  monitor ing forward and 
r e f l e c t e d  power, temperature,  and phys io log ica l  parameters ( r e f .  8) * While 
c u r r e n t l y  be ing  opera ted  a t  915 MHz, t h e  c o n t r o l  system is frequency-indepen- 
dent  and w i l l  be  opera ted  a t  a lower frequency when c l i n i c a l  t r ials  commence. 
By us ing  t h e  dual-beam system, we found t h a t  t h e  c e n t r a l  a x i s  t i s s u e  
temperature p r o f i l e  is p a r a b o l i c  as would be p r e d i c t e d  by supe rpos i t i on  of 
energy depos i t i on  i n  t i s s u e .  I n  tumor regrowth s t u d i e s ,  us ing  C3H murine 
mammary carcinomas t r ansp lan ted  t o  t h e  f l a n k ,  w e  have found t h a t  t h e  de lay  
i n  regrowth fol lowing t rea tment  compares favorably  w i t h  ou r  previous water 
b a t h  s t u d i e s  ( r e f s  1 t o  3) . Our programmable system is under eva lua t ion  and 
sof tware  development. It i s  c u r r e n t l y  be ing  used t o  s tudy  t h e  e f f i c a c y  of 
focussed h e a t i n g  i n  a f e l i n e  b r a i n  through measurement of e l e c t r i c  and re- 
s u l t a n t  thermal  f i e l d s  (wi th  Narda and Ramal implantable  probes) .  
 his work w a s  supported i n  p a r t  by N I H  Grant CA 18807-02 and ACS Grant 
PDT-105. 
A t  present ,  the  major l i m i t a t i o n s  of the  use of microwave diathermy f o r  
cancer thermotherapy i s  the  equipment's a b i l i t y  t o  heat  deep tumors while 
sparing the  intervening t i s sue .  With development of equipment and techniques 
f o r  focussing t h e  heat  t o  t h e  tumor s i t e ,  w e  expect t o  improve t h e  u t i l i t y  
of loca l i zed  microwave-induced hyperthermia a s  an adjunct to  radiotherapy 
and chemotherapy i n  the  c l i n i c a l  management of some cancers and espec ia l ly  
malignant b ra in  tumors. 
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Questions and Answers Following Samaras' Paper 
Singh: What i s  t h e  beam s i z e ,  t h e  physical  width, i f  you w i l l ,  of t h e  
beam? 
Samaras: I am going t o  t r y  and br ing  t h a t  up i n  t h e  next  point .  The 
app l i ca to r s  t h a t  we a r e  using a r e  these  d ie lec t r i ca l ly - loaded  "waveguides." 
This was presented a t  t h e  A i r l i e  House meeting l a s t  September, I th ink.  
I t  was by D r .  Chung and m e .  What we have done i s  t h a t  we have taken a 
1 centimeter  by 2 centimeter  ba r  of t i tanium dioxide and pain ted  on t h e  
surface  with DuPont de Nemours conductive p a i n t  a waveguide, i n  e f f e c t .  
So, we have an a p p l i c a t o r  the  s i z e  of an X-band waveguide with a cutoff  
frequency a t  700 megahertz. For t h e  prel iminary experiments, o r  f o r  t h e  
labora tory  p r e c l i n i c a l  experiments, t h a t  we a r e  doing, we a r e  opera t ing  a t  
915 megahertz and us ing f e l i n e  bra in .  Does t h a t  answer the  quest ion about 
the  ape r tu re  s i z e  s u f f i c i e n t l y ?  
Regelson: There might be another  way t o  approach t h i s .  That i s ,  the  tech- 
nology i s  he re ,  and it is done c l i n i c a l l y  t o  introduce a r t e r i a l  c a t h e t e r s  
t o  inc lude  por t ions  of  t h e  blood supply t o  regions  of t h e  bra in .  We a r e  
doing t h i s  now. I f  anyone i s  i n t e r e s t e d ,  I could provide you with s t a r c h  
microspheres, which a r e  d iges ted  by amylase. When introduced i n t r a -  
a r t e r i a l l y ,  they can g ive  you a r e v e r s i b l e  occlusion t h a t  can be timed, 
depending upon how we polymerize and what s i z e  of t h e  spheres we give you. 
I can make them ava i l ab le  t o  you, b u t  i n  t h e  b r a i n  t h e  speed of t h e  
depolymerization would be  too  long f o r  it t o  be used. It could be used i n  
o the r  organ systems. But, you could use  bal loon c a t h e t e r s ;  and by denying 
a r t e r i a l  supply you w i l l  decrease h e a t  d i s s i p a t i o n ,  and thus  you might g e t  
h o t  spots .  I wonder whether o r  not  t h a t  might be another  way f o r  you t o  do 
t h i s ,  a p a r t  from t h e  focusing technique t h a t  you a r e  so i n t e r e s t e d  i n .  
Samaras: You mean i n  conjunction with t h a t  o r  a s  an a l t e r n a t i v e ?  
Regelson: Well, you could r a d i a t e  t h e  whole head; but  by taking t h e  region 
of t h e  tumor, you can l o c a l i z e  t h e  blood supply t o  a degree. You then pu t  
a bal loon c a t h e t e r  up i n  the re .  You occlude f o r  wi th in  t h e  5-minute per iod  
t h a t  you can occlude without severe ly  damaging normal t i s s u e .  O r ,  you can 
go beyond t h a t  because your regional  l o c a l i z a t i o n  can be t h a t  good. Then, 
you whole-brain r a d i a t e  with your microwaves, expecting t h a t  the  a rea  t h a t  
does no t  have the  a r t e r i a l  supply i s  going t o  g e t  h o t t e r .  I wonder whether 
t h a t  i s  an opt ion  t h a t  you could use. 
Samaras: What about the  time, though? 
Regelson: Well, I mean, again, you have t o  work it ou t  empir ica l ly ,  and 
the  only way you a r e  going t o  do i t  is  t o  t r y .  
Samaras: No, I a m  saying i f  you could only occlude f o r  a period of 
5 minutes, t h a t  might no t  be long enough. 
Regelson: No, you can go beyond t h a t ,  bu t  you a r e  going t o  g e t  an i n f a r c t .  
O.K. So what you want t o  do, of course,  i s  t o  g e t  a g rad ien t  e f f e c t  
r e l a t e d  t o  t h e  a r e a  of involvement. I th ink  t h a t  i s  t h e  way you can go 
provided you c l o s e l y  con t ro l  the  time t h a t  you produce the  occlusion.  
You would g e t  a r e a l  h o t  s p o t ,  I would th ink ,  because you a r e  not  g e t t i n g  
a r t e r i a l  blood profusing t h e  a rea ,  and t h e  temperature i s  going t o  s t a y  
the re .  
Samaras: To d i f f u s e  t h e  heat ing ,  yes. 
Singh: Apparently, you a r e  going t o  have a predetermined temperature i n  
t h e  region where t h e  tumor is. Would t h a t  be j u s t  l i k e  t r i a l  and e r r o r ,  o r  
would you have a way of a c t u a l l y  c o n t r o l l i n g  i t ?  
Samaras: We hope t h a t  we a r e  going t o  be a b l e  t o  monitor intraturnor 
temperature i n  the  animals, c e r t a i n l y ,  wi th  a temperature probe i n  t h e  
cen te r  of t h e  tumor. In t h e  human p a t i e n t s  down t h e  l i n e ,  u l t ima te ly  
most of  these  people w i l l  have been through a craniotomy, and it w i l l  be 
no problem. They have a b u r r  hole  the re  t h a t  you can drop t h e  probe in to .  
Did I understand t h e  ques t ion  properly? 
Singh: W e l l ,  yes ,  b u t  I am no t  f u l l y  sure  i f  I d id  g e t  the  answer; but  
s ince  it i s  down t h e  l i n e ,  I suppose t h a t  i s  a l r i g h t .  
Samaras: What I am saying i s ,  yes,  we expect  t o  be monitoring t h e  core  
temperature of t h e  tumor on l i n e  while we a r e  doing t h e  heat ing.  It i s  t o  
c l o s e  t h e  loop. 
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Samaras: W e l l p  I guess  the  f i r s t  th ing  t h a t  I would l i k e  t o  bring up about 
methods of heat ing,  and I th ink one t h a t  is con t rovers i a l ,  is t h e  d i f fe rence  
between whole-body heat ing and loca l i zed  hyperthermia, Does anyone want t o  
make any comments about t h a t ?  
Regelsoni I would j u s t  l i k e  t o  address a quest ion i n  regard t o  methodology. 
There is  work i n  bas ic  biology i n  r e l a t i o n  t o  t h e  use of poiki lothermic cells 
i n  t i s s u e  c u l t u r e j  f o r  example, one very good model is  t h e  f a t  head minow. 
You dea l  with a f i s h ,  and you qrow its cells, and it can grow a t  room temper- 
a tu re ,  Now, when you r a i s e  the  temperature, you d r i v e  cell  d i v i s i o n  a t  
d i f f e r e n t  r a t e s ,  People have s tudied  DNA and RNA syn thes i s  i n  r e l a t i o n  t o  
these  r e l a t ionsh ips ,  Is anybody u t i l i z i n g  these  models i n  r e l a t i o n  t o  micro- 
wave e f f e c t s ?  
Samarasr Not t h a t  I know of.  Does anyone have any comments t o  make about 
t h a t ?  
Singh: No, but  I th ink  I miqht ask a d i f f e r e n t  question. Is n o t  t h e  whole- 
body heat ing,  i n  f a c t ,  being used by d e f a u l t ?  I mean, i f  one could have 
loca l i zed  heat ing,  o r  focused heat ing@ one would not  want t o  do whole-body 
heat ing,  Is t h a t  not  r i g h t ?  
Samarast Well, t h a t  has always been my fee l ing .  But, Ron Atkinson, who i s  
one of t h e  i n t e r n a t i o n a l  proponents of  whole-bodv heat ing,  could help u s  with 
t h a t .  
Singhc Oh, perhaps, w e  should ask D r .  Atkinson then,  Would t h e r e  be any 
reason why you would want whole-body, a s  opposed t o  local ized ,  heat ing? 
Atkinson: Well, l e t  me say t h a t  i n  t h e  treatment of disseminated d i sease ,  
it w u l d  be most d e s i r a b l e  t o  t r e a t  systemical ly,  r a t h e r  than loca l ly .  For 
t h i s  reason w e  have been very much i n t e r e s t e d  i n  whole-body hyperthermia. Of 
course, you a r e  r e s t r i c t e d ,  w e  th ink ,  t o  temperatures below o r  a t  42O C. 
This is a l i m i t a t i o n  of t h e  whole-body heat ing method. I th ink i f  you would 
have asked m e  t h i s  ques t ion  a year  ago, I would have said:  "Local hyperther- 
mia i s  much e a s i e r  t o  do than whole-body." I th ink  back about t h e  l a s t  v e a r Q s  
experience I have had with whole-body hyperthermia, and I have t o  absolute ly  
reverse  t h a t  pos i t ion .  While playing around with l o c a l  hyperthermia f o r  a 
year,  I ran  i n t o  a l l  s o r t s  of d i f f i c u l t i e s  i n  temperature measurement, con t ro l  
l o c a l i z a t i o n  of t h e  heat ,  and t h e  var ious  problems which I am s u r e  vou a r e  a l l  
f ami l i a r .  I can say t h a t  it appears t h a t  whole-body hyperthermia i s  a u i t e  a 
b i t  simpler,  a t  t h e  p resen t  s t age  of technoloqy, than l o c a l  hyperthermia. 
Have I answered your quest ion? 
Singh: Yes, you d id ,  But, i f  you could focus it reasonably e a s i l y c  would YOU 
p r e f e r  t o  l o c a l i z e ?  
Atkinsonr Y e s ,  except  f o r  tKe f a c t  t h a t  t h e  i n t e r e s t  i n  cancer t reatment,  o r  
a l a r g e  p o r t i o n  of t h e  i n t e r e s t  i n  cancer treatment, is  i n  t r e a t i n g  dissemi- 
nated d isease ,  r a t h e r  than l o c a l  d i sease .  There e x i s t s ,  already,  radio- 
therapy and surgety  as treatment moda l i t i e s  f o r  loca l i zed  d i sease ,  
Samarasr Ronl could I ask you a ques t ion ,  p lease?  What about t h e  problem 
of thermal uniformity,  thoughl i n  whole-body hyperthermia? You do n o t  r e a l l y  
have t r u e  thermal uniformity i n  heat ing t h e  whole body. We w e r e  d iscuss ing 
t h a t  on t h e  p lane  r i d e  down, How do you? You were t a l k i n g  about disseminated 
d i s e a s e  and t ry ing  to r a i s e  t h e  whole body t o  42O C. Do you th ink  t h a t  g i v e s  
a the rapeu t i c  benef i t ?  
Atkinson: Y e s ,  l e t  m e  say t h i s .  I f  we t a l k  about nominal 42O c whole-body 
hyperthermia, t h i s  is  r e f e r r i n g  t o  42O c t i s s u e  temperature. Blood t e m ~ e r a -  
t u r e l  t y p i c a l l y ,  w i l l  s i t  a t  about 41.8~ C; and sk in  temperature, a t  around 
40° C ,  o r  perhaps s l i g h t l y  higher than 40° C. The t i s s u e  temperature, we 
bel ieve,  i s  q u i t e  uniform, except,  perhaps, i n  s p e c i f i c  organs, i n  which it 
i s  higher,  The b e s t  we can t e l l  a t  the  p resen t  time is  t h a t  these  a r e  higher 
than t h e  nominal t i s s u e  temperature of 42O C. W e  f e e l  conf ident  t h a t  no p a r t  
of t h e  p a t i e n t  -- with t h e  poss ib le  exception of t h e  a c t u a l  sk in  surface ,  
wh>h we  a r e  cool ing  t o  maintain t h e  p a t i e n t  a t  h i s  temperature s o  t h a t  w e  do 
n o t  have thermal runaway -- is  below 42O C. I th ink  t h i s  i s  a f a i r l y  s a f e  
assumption. 1.f I could say t h e  same about any l o c a l  hyperthermia treatment,  
I would say t h a t  t h e  s t a t e  of t h e  art i n  l o c a l  hyperthermia had exceeded t h i s  
capaci ty ,  
Samarasr The reason I asked t h e  ques t ion  was because o f  t h e  poss ib le  stimula- 
t o r y  e f f e c t s  yhen you a r e  below t h a t  temperature. I f  we a r e  t a lk ing  about 
42O C i n  one region with a malignancy and 40° C o r  40,5O C, i n  another region 
with a malignancy, then you a r e  n o t  g e t t i n g ,  a t  l e a s t  from t h e  labora tory  
experiments, remission, 
Atkinson: W e l l ,  w e  have c a r e f u l l y  looked f o r  evidence of s t imula tory  e f f e c t s  
of subtherapeutic .  We have not  found any ourse lves ,  nor have we seen any 
ins tance  of t h i s  being reported i n  t h e  l i t e r a t u r e .  Occasionally, you hear  
of unpublished r e p o r t s  where the re  a r e  ind ica t ions  on t h e  b a s i s  of a few t r i a l s  
t h a t  s o m e  of t h e  animals appeared t o  have a decrease i n  l i f e  span. But, i f  I 
look a t  where the  arrow bars  a r e  and the  number of animals involved, I have 
not  seen any. Cer ta in ly  none of t h i s  has been published. W e  would l i k e  very 
much t o  know i f  t h i s  i s  a r e a l  e f f e c t .  I n  t h e  FDA testimony and hearinqs t h a t  
we have had about the  use of diathermy i n  the  treatment of malianancy, t h e  
FDA-tried to p i n  t h i s  down, They could not  succeed i n  cominq up with any 
evidence t h a t  t h e r e  is  a de le te r ious  e f f e c t  i n  t h e  treatment o f  cancer,  I am 
not  an exper t  i n  metas tas is ,  but  t h e r e  c e r t a i n l y  is  an increase  i n  c e l l  shed- 
ding of tumors a t  elevated temperatures. Naively, I i n i t i a l l y  thouqht t h a t  
t h i s  indica ted  an increase  i n  p r o l i f e r a t i o n .  But, it t u r n s  ou t ,  I am t o l d ,  
and I have no d i r e c t  experience with t h i s  myself, t h a t  t h i s  i s  not  necessa r i ly  
i n d i c a t i v e  of an increase  i n  metastasis .  Indeed those experiments t h a t  have 
been done i n d i c a t e  t h a t  with ex te r io r i zed  r a t  ova r i e s ,  f o r  ins tance ,  i n  one 
experiment I have i n  mind, although tumor c e l l  sheddinq increases  a t  elevated 
temperatures, t h e r e  is no corresponding increase  i n  metastasis .  So, it is 
s t i l l  a somewhat open quest ion,  bu t  it is a matter  t h a t  does not  g i v e  m e  
se r ious  concern, 
Shaefferr Dixon and h i s  col league i n  Great B r i t a i n  have published r e s u l t s  
r e l a t i n g  to  the  Yoshida tumor i n  r a t s ,  and I a l s o  bel ieve  t h e  VX2 carcinoma 
i n  r a b b i t s ,  i n  which* when they gave what they considered t o  be inadequate 
doses of hyperthermia, t h e r e  were demonstrable d i f fe rences  o r  increases  i n  t h e  
number of hematogenous metastases. And, when you a r e  heatincr your p a t i e n t s ,  
you know they have t o  pass  throuqh some c r i t i c a l  l e v e l  of  suboptimal hyper- 
thexmia on t h e  way up t o  the  des i red  temperature and a l s o  a s  they cool down, 
I was wondering what comments you might have about t h i s ;  i .e. ,  about t h e  
enhancement of me tas tas i s  by suboptimal o r  subtherapeutic  hvper themic  l e v e l s ,  
Atkinson: I was unaware of the  Yoshida, bu t  I knew about t h e  experiment with 
t h e  VX2 and t h e  r a b b i t ,  and it was a one-rabbit experiment; t h a t  is, only one 
of h i s  r a b b i t s  survived t h e  whole-body hvperthermia. So, I do no t  know about 
t h a t .  I s h a l l  ask about t h e  Yoshida, though. I would be i n t e r e s t e d  t o  know. 
Shaefferz I was ref  e r r inq  t o  t h e  Dixon and Muckle paper, 
Harrison8 You could ask the  same ques t ion  about l o c a l  hyperthermia. Robinson 
d id  a mouse experiment t o  look f o r  lung metas tas is ,  and w e  a r e  i n  t h e  process 
of wr i t ing  it up. We see  t h a t  t h e r e  is  no change with heating, o r  e l s e  a 
decrease i n  metas tas is .  I a l s o  th ink  of Szmiuie lski ' s  work i n  Poland, H e  
seems t o  have some hard evidence t h a t  loca l i zed  hyperthermia a c t u a l l y  stimu- 
l a t e s  some mechanism which i n h i b i t s  me tas ta t i c  growths elsewhere from t h e  
t r e a t e d  volume. 
Samarast On t h e  o t h e r  handp though, t o  be f a i r  t o  both s i d e s l  you a r e  
absolute ly  r i g h t  t h a t  whole-body hyperthermia, r i g h t  now, i s  t h e  only game 
i n  town. I t  is  s o  much s o  t h a t  we a r e  planning on cranking up c l i n i c a l  t r i a l s  
with whole-body hyperthermia f o r  b ra in  tumors i n  conjunction with t h e  BCRC. 
Regelson: There a r e  people involved i n  l o c a l  hyperthermic approaches c l i n i -  
c a l l  ye  
Samarasr Are they t r e a t i n g  b ra in  tumors? 
Regelsont They a r e  not  t r e a t i n g  b ra in  tumors, bu t  o the r  tumors, Durant has 
successful ly ,  well no t  q u i t e  successful ly ,  t r e a t e d  a p a t i e n t  of mine with 
schwannoma, me tas ta t i c  t o  lung. Unfortunately, he d i d  not  r a d i a t e  t h e  lunq 
parenchyma i t s e l f ,  bu t  he t r e a t e d  a subs ternal  mass which decreased 50 percent  
by volume, This  confirms Hol t ' s  work i n  Perth;  he reported on a schwannoma i n  
the  head and neck region t h a t  melted away with h i s  434 megahertz machine. A s  
I was saying to  Ron e a r l i e r ,  I th ink t h a t  somebody from t h e  N C I  with sophis- 
t i c a t i o n  should t ake  a look a t  Halt's program i n  Per th  because vou cannot 
d iscount  Holt ,  Anybody who is repor t ing  65-percent, 3-year survival  of 
r ecur ren t  head and neck cancer, p o s t  radio-therapy followinq heat ,  i s  somebody 
you have t o  pay a t t e n t i o n  to .  He i s  e i t h e r  t h e  b igqes t  l i a r  i n  t h e  business,  
o r  he has g o t  something t h a t - h a s  t o  be looked a t ,  He claims he has enough 
numbers now f o r  t h i s  t o  be va l id ,  and somebody has t o  qo t o  Per th  and look 
a t  t h i s ,  i n s t ead  of ignoring t h e  man, W e  have go t  t o  do something about it 
because it might speed up t h e  r a t e  a t  which t h i s  g e t s  i n t o  t h e  c l i n i c .  
Samarass W e l l ,  I th ink  t h a t  people i n  Indiana a r e  qoinq along q u i e t l y  doing 
some of t h i s  workp and probably t h e i r  r e s u l t s  should be ab le  t o  answer some of 
those  ques t ions ,  I th ink  they a r e  working a t  t h e  same frequency, b u t  not  with 
Hol t * s machine. 
Atkinson: I am a cochairman of t h e  Fourteen un ive r s i ty  Cooperative RL'OG Proto- 
c o l  f o r  l o c a l  hyperthermia i n  t h e  treatment of cancer, Most of t h e  p a r t i c i -  
pa t ing  i n s t i t u t i o n s  have s t a r t e d  p i l o t  s tud ies .  The protocol  was j u s t  issued 
about a month ago by the  American College of Radiology under NCI sponsorship. 
We a r e  expecting some good d a t a  t o  be generated over t h e  course of t h e  next  
year  o r  s o  f o r  l o c a l  hyperthermia. You a r e  q u i t e  r i g h t .  To my knowledqe, 
t h e r e  is  only some very prel iminary experimental work goinq on i n  l o c a l  
hyperthermia f o r  b ra in  tumors, however. 
Singhe May I ask a ques t ion ,  D r .  ~ t k i n s o n ?  Has t h e r e  been any important use  
of ul trasound f o r  l o c a l  hyperthermia? 
Atkinson: Yes, I can suqgest two persons t o  contac t  i n  r e sa rd  t o  t h i s  a t  
Sanford University. George Hahn is  working with ,lane Marmur i n  t h e  use  of 
ul trasound c l i n i c a l l y  f o r  l o c a l  hyperthermia, They can g ive  you t h e  d e t a i l s ,  
I j u s t  simply know t h a t  it e x i s t s ,  and I know more about George's animal 
s t u d i e s  than I do t h e  c l i n i c a l  work. I have n o t  v i s i t e d  him s ince  he s t a r t e d .  
Regelsonr There i s  a big program with Bowman-Gray with ul trasound f o r  c l i n i -  
c a l  use  i n  conjunction with radio-therapy, 
Carr: With regard to l o c a l  versus  whole-body, i f  you could l o c a l l y  hea t  a 
tumor, what would be t h e  upper l i m i t ,  o r  what temperature would you want t o  
hea t  it to?  I know t h a t  you a r e  l imi ted  because of damage t o  surrounding 
t i s s u e ,  If you could hea t  l o c a l l y ,  what temperature would you s t r i v e  f o r ?  
Samarass W e l l ,  our  f e e l i n g  a t  Maryland from Robinson's animal experiments 
is  t h a t  probably about 44O C t o  45O C is  i d e a l ,  
Carro What is  t h e  problem of going higher, i f  you d i d  not  damage t h e  sur- 
rounding t i s s u e -  If you could l o c a l l y  h e a t  only a tumor, what would be t h e  
problem i n  going t o  a higher temperature? 
Samarasr I th ink  t h a t ,  r a t h e r  than decreasing r e p a i r  followinq r a d i a t i o n  
damage, o r  increas ing t h e  e f f e c t  of chemotherapeutic aaents ,  you would merelv 
be cau te r i z ing  the  tumor. I do n o t  know t h e  answer t o  t h a t  aues t ion .  
Carrr ~ e g a r d i n g  whole-body versus  l o c a l i z e d , . i u s t  what temperature a r e  you 
going t o  l i m i t  yourself  to? 
Samarast Can you answer t h a t  ques t ion  Don? 
BaMerg I can only say t h a t  I have spent  a l i t t l e  t i m e  with D r ,  LeVeen i n  
New ffork, H i s  i dea  i s  t o  g e t  the  tumor temperature up i n t o  t h e  mid 50° C 
range, He does t h i s  with the  idea  t h a t  he can des t roy the  tumor cells with- 
ou t  any use o f  any o t h e r  modality. He depends on t h e  f a c t  t h a t  t h e  tumor i s  
unable t o  d i s s i p a t e  t h e  hea t  a s  r ap id ly  a s  t h e  normal t i s s u e .  So, on t h i s  
b a s i s  he t r y s  t o  g e t  tumor t e m ~ e r a t u r e s  i n t o  t h e  mid 50%. Apparently, he 
has succeeded, a t  l e a s t  occas ional ly ,  i n  doinq t h i s ,  
Samaras: I had a ques t ion  about t h a t  myself, Except f o r  t h e  nec ro t i c  cen te r  
where you do not  have t h a t  much vascula ture ,  how about the  h iahly  vascular ized  
periphery and the  p o s s i b i l i t y  of leavinq behind even one l i v e  tumor c e l l  t o  
s t a r t  t h e  whole cycle  a l l  over again? How does he handle t h a t  problem? 
Bakers I cannot r e a l l y  answer your ques t ion  d e f i n i t i v e l y  because I do no t  
know what he says. But, as f a r  a s  I could t e l l  from spendinq some time and 
watching him t r e a t  two o r  t h r e e  p a t i e n t s ,  it seems t h a t  t h e  method he was 
using was e f f e c t i v e  -- only i f  t h e r e  was a s i g n i f i c a n t  vascular  d e f e c t  i n  t h e  
tumor, and i f  the  hea t  d i s s i p a t i o n  was much l e s s  t h e r e  than i n  t h e  surrounding 
normal t i s s u e s  which contained the  pa th  of t h e  r a d i o  beam. So, presumably, 
i n  highly vascular ized  tumors, h i s  method would produce no s i g n i f i c a n t  advan- 
tage. But, h i s  argument is  t h a t  near ly  a l l  t he  tumors t h a t  he was deal ing 
with were se lec ted  on the  b a s i s  of t h e i r  h i s t o l q y  and had indica ted  poor 
c i r cu la t ion .  
Beeben LeVeen f e e l s  t h a t  tumors a r e  very poorly profused compared with sur-  
rounding t i s s u e s  -- on an order  of 10  percent .  That i s  the  b a s i s  f o r  h i s  
f e e l i n g  t h a t  they cannot d i s s i p a t e  the  heat .  And, he f e e l s  t h i s  i s  t r u e  f o r  
tumors i n  genera l ,  r eqa rd less  of what type,  Also, i n  one of h i s  paDers, i n  
1976, he s e l e c t e d  four  o r  f i v e  d i f f e r e n t  types of tumors, 
Samaras: I am not  an oncologis t  o r  a pa tho log i s t ,  b u t  I was under the  impres- 
sion, from t h e  work a t  Harvard o f  Judah Folkman, t h a t  a t  l e a s t  i n  t h e  e x t e r i o r  
regions t h e  tumor a t t r a c t s  t h e  blood supply t o  it and, i n  f a c t ,  becomes h iahly  
vascularized.  So, I do not  q u i t e  understand how t h e  two can be happening 
simultaneously . 
Baker: Well, i f  you genera te  a l a r g e  amount of heat ,  then vou a r e  going t o  
have a temperature g rad ien t ,  and t h i s  mav simply overpower t h a t  narrow r i n  
of vasculature.  
Sm.arass I see. That is  c e r t a i n l y  a p o s s i t i l i t y .  
~ a k e r :  Inc ident ly ,  I saw a case record of one bra in  tumor t h a t  he d id  t r e a t ,  
and he g o t  complete remission. The whole th ing became a cys t ,  which was 
drained out;  and t h e  ~ a t i e n t  is a l ive .  
Samarasr I would l i k e  t o  bring up what D r .  Atkinson was t a lk inq  about e a r l i e r  
i n  terms of the  l e g a l  a spec t s  of  doing c l i n i c a l  t r i a l s .  I am involved with 
some loca l i zed  c l i n i c a l  t r i a l s  i n  microwave hyperthermia f o r  skin cancers 
a t  Maryland. I am looking i n t o  t h e  l e g a l  l i a b i l i t y  because I fabr i ca ted  
the system t h a t  is  going to -be  used i n  t r ea t i ng  the pa t ien ts .  We go t  a 
reading from the S t a t e  Attorney General" Office saying t h a t  I would be held 
personally l i a b l e  f o r  the  treatment and a l so  f o r  the product l i a b i l i t y ,  That 
i s  something t h a t  I think should be taken i n t o  consideration by people who a r e  
not covered by insurance pol ic ies :  e,g,, non-clinicians, o r  nurses. 
Regelson: What about informed consent? Are you not covered by your invest i -  
gat ions  committee with informed consent? 
Samaras: The c l i n i c a l  t r i a l s  a re  approved by the  Human Experimentation 
Committee. A t  l e a s t  i n  t h e  S t a t e  of Maryland, the  informed consent i s  not 
a consent t o  negligence or  to accidents. So, t h a t  does not cover you, i n  the  
leas t .  
Regelson: Well, i f  you have an accident, t h a t  is  another s tory,  
Samaras: Well, t h a t  i s  a l l  we a r e  ta lking about. We are  not ta lking about 
de l ibera te ly  going and hurting someone. Yes, S i r .  
Hobson: I have been involved i n  t h i s  f o r  a long time. The informed consent 
does not, i n  any wayr re l ieve  you from responsibi l i ty .  The legal  pr inciple ,  
I am to ld ,  and I am not a lawyer, i s  t h a t  no one can sign away h i s  r i g h t s  t o  
claim t h a t  he has been damaged a s  a r e s u l t  of par t i cu la r ly  unorthodox prscs- 
dures. SO, you have no protect ion f o r  the  invest igator  from the pa t i en t  who 
has signed an informed consent. 
Samarass And, i f  one of the  invest igators  a l so  happens t o  be the  manufacturer 
of the  machine, you have double jeopardy. 
Shaeffert I would l i k e  t o  move on now t o  t he  next session, Thermal Measure- 
ments, The moderator f o r  t h i s  session w i l l  be D r .  Jag Singh from the  NASA 
Langley Research Center. D r .  Singh. 
THERMAL MEASUREMENTS IN HYPERTHERMIA 
Moderator: Dr. Jag J. Singh, NASA Langley Research Center 
Introductory Remarks by the Moderator: 
Several papers presented in the morning session had cited the need for 
accurate temperature measurements - both for thermal bath (whole body) studies 
as well as localized heating induced by electromagnetic radiation. Langley 
scientists, at the request of clinical researchers at EVMS, MCV, and the 
Veterans Administration Center, have been studying this problem for some time. 
The thermal measurement problem can be approached in two ways: 
1. Temperature Measurements Concurrent with Diathermy. These measurements 
require that the "thermometer" not interfere with the heat distribution or 
interact with the heat-inducing radiation. The following two noninvasive'- 
techniques fall in this category: (a) microwave radiometry, (b) acoustic 
thermometry. 
2. Temperature Measurements Following Diathermy. Invasive thermometers - 
such as thermocouples and thermistors - can be used for such measurements. 
The noninvasive techniques - microwave/acoustic radiometry - are ideal for 
measuring the temperature of the suspected tumorous region as well as providing 
a feedback signal to control the heating level. 
Langley is currently involved in the development of a microwave radiometry 
system for microwave hyperthermia. We are also developing a thermocouple-based 
controllable RF heating system to provide a predetermined level of heating to 
test mice. Proper orientation of the thermocouple leads as well as the use of 
an RF filter eliminate the interference from the RF field in the test region. 
I will be glad to discuss our work in detail if the audience so desires. 
This session is now open for general audience participation. 
session-2: Thermal Measurements 
Moderator : Jag J. Singh 
Singh: Several papers presented in the morning session cited the need for 
accurate temperature measurements, both for thermal bath (whole-body) studies 
and for localized heating induced by electromagnetic radiation. Langley 
scientists -- at the request of clinical researchers at the EVMS, MCV, and 
Veterans Administration -- have been studying this problem for some time. 
The thermal measurement problem can be approached in two ways. The first 
approach is to make temperature measurements concurrent with diathermy. 
These measurements require that the "thermometer" not interfere with the 
heat distribution or interact with the heat-inducing radiation. The two 
noninvasive techniques, microwave radiometry and acoustic thermometry, fall 
into this category. The second approach is to make temperature measurements 
following diathermy. Invasive thermometers, such as thermocouples and 
thermistors, can be used for such measurements. The noninvasive techniques, 
microwave and acoustic radiometry, are ideal for measuring the temperature 
of the suspected tumorous region, as well as providing a feedback signal to 
control the heating level. Langley is currently involved in the development 
of a microwave radiometry system for microwave hyperthermia. We are also 
developing a thermocouple-based, controllable RF heating system to provide a 
predetermined level of heating to test mice. Proper orientation of the 
thermocouple leads, as well as the use of an RF filter, eliminate the 
interference from the RF field in the test region. I will be glad to dis- 
cuss our work in detail, if the audience so desires, This session is now 
open for general audience participation. 
Samaras: Obviously, I would like to be able to measure the temperature 
simultaneously so that we could use it to close the feedback loop. It would 
be preferable if we could have something like three-dimensional microwave 
thermography. 
Singh: That is a very good idea. Maybe, Ken Carr could address that one. 
How far are we from providing the simultaneous temperature measurement for 
microwave hyperthermia? 
Carr: Okay, I think the microwave radiometry is equivalent, of course, to 
infrared. Only, hopefully you would be able to look below the surface. 
Now, for any hot-body radiator the optimum emission frequency is in the 
infrared. However, in getting to the surface you go through a great deal of 
dispersion, so what you are really measuring in infrared is the surface 
temperature, but what you would like to do is Look deeper. The deeper you 
look -- or the closer to the tumor, or the hot spot, you are measuring -- 
the more accurate will be the reading you get. Now, you would like to 
measure temperature simultaneously. For this you would have to be operating 
at two different frequencies. Also, you would have to separate the two 
systems because, if you are going to be heating, your microwave radiometer 
is a very sensitive device, and you would wipe it out. One thing that I 
caution everyone on in using these microwave generators that you are using 
is that they are called dirty generators. They call such rich in harmonics 
because it sounds b e t t e r  and s e l l B  t h e  instrument b e t t e r .  But, t h e  harmonics 
you do no t  want! The harmonics, of course,  would wipe out  instrumentat ion a t  
t h e  higher frequencies.  So, a l l  your measurements should be  made with 
proper f i l t e r i n g ,  so you a r e  no t  g e t t i n g  some unknown s ide  e f f e c t  of  some 
harmonic you d id  n o t  p lan  on. I n  most of  t h e  microwave genera tors ,  t h e  
second harmonic l e v e l  i s  suscep t ib le  t o  t h e  maps t h a t  you a r e  looking a t .  
Also, it i s  only 3 o r  4 dB down from t h e  fundamental i n  a l o t  of these  
devices,  and s o  you should r e a l l y  f i l t e r .  But, I would agree  with George. I 
would want t o  measure temperature simultaneously and c lose  t h e  loop. But, t o  
do t h a t  you would be using two d i f f e r e n t  frequencies.  
Singh: Let  me j u s t  make one comment. That i s ,  I th ink you can do t h e  I R ,  a s  
w e l l .  It is  t r u e  t h a t  you can make only a sk in  temperature measurement, 
But, i f  you had a l i g h t  guide -- l e t  u s  say, f o r  example, a s i l i c o n  dioxide 
l i g h t  guide, t h a t  i s  going r i g h t  i n t o  t h e  region you want t o  look a t  -- and 
a proper band pass  and a wavelength i n  the  range of about ha l f  a micron t o  
5 - 6 microns, then you can use a r egu la r  I R  d e t e c t o r ,  a gold-doped 
germanium d e t e c t o r ,  cooled t o  l i q u i d  helium temperature. It w i l l  work very 
well .  
Carr: Well, you g e t  a t rade-off .  I n  o t h e r  words, a s  you go higher i n  
frequency, your tumor, o r  your h o t  s p o t ,  i s  emit t ing  more energy. 
Singh: Well, yes,  you a r e  q u i t e  r i g h t ,  b u t  you can e a s i l y  make t h e  ca lcula-  
tion:. For black-body r a d i a t i o n  the  range is  reasonable enough. It i s  well  
ou t s ide  the  minimum l i m i t  t h a t  we need, i n  order  t o  g e t  above t h e  background- 
l e v e l  s i g n a l  from t h i s  I R  d e t e c t o r  I was t a l k i n g  about .  W e l l ,  I th ink it i s  
a good thought, though, t h a t ,  i f  you can use microwaves, then I R  should no t  
be ru led  ou t .  
Beebe: I was thinking about your suggest ion,  Ken, on two d i f f e r e n t  frequen- 
c i e s .  Perhaps, you could use t h e  same frequency and j u s t  momentarily t u r n  
t h e  r a d i a t i o n  o f f  from t h e  therapy and measure t h e  r a d i a t i o n  t h a t  i s  then 
coming from t h e  tumor. That way, you could use  t h e  same frequency, i f  it 
turned o u t  t o  be an optimal  frequency. 
Carr: That i s  t r u e .  I f  you could duplex -- i n  o t h e r  words, be heat ing  one 
po in t  and then,  of course,  sensing another  -- t h a t  would c e r t a i n l y  be 
adequate. Normally, you would probably l i k e  t o  keep the  h e a t  cons tant .  You 
could c e r t a i n l y  duplex. 
Buckley: Yes, Ken, why n o t  j u s t  pulse  i t ?  My gosh, you do nanoseconds i n  
terms of e l e c t r o n i c s .  The body i s  no t  t h a t  good of  a heat - t ransfer  agent .  
J u s t  pulse  t h e  th ing  i n  nanoseconds o r  microseconds. 
Carr: That i s  t r u e .  And, by t h e  way, once you s t a r t  hea t ing ,  i f  you do g e t  
the  d i f f e r e n t i a l  i n  h e a t  which you have a l l  s a i d  you do between t h e  sur- 
rounding t i s s u e  and the  tumor you a r e  heat ing ,  then the  t a r g e t ,  o r  t h e  tumor, 
s tands  o u t  more. It becomes more pronounced and e a s i e r  t o  f i n d  with 
sensoring devices ,  so it makes t h e  loop e a s i e r .  
Singh: Very good. Let  us see .  D r .  Atkinson has something t o  say. 
Atkinson: I f  you a r e  r e f e r r i n g  t o  t h e  microwave radiometry, indeed t h e  
puls ing  technique would be q u i t e  e f f e c t i v e .  We have found t h a t  the  
puls ing  technique i s  s l i g h t l y  e f f e c t i v e  i n  adversely placed thermocouples. 
The problem the re ,  however, i s  t h a t  t h e  e l e c t r i c  f i e l d  hea t s  t h e  transducer 
s e l e c t i v e l y  t o  the  t i s s u e ,  and t h a t  i s  what I mean by an adversely placed 
thermocouple. However, an on-off technique is e f f e c t i v e ;  and, where s a f e t y  
i s  no t  a major cons idera t ion ,  such a s  i n  animal experiments, it is indeed 
q u i t e  f e a s i b l e  t o  use pulsing.  
Singh: Well, b u t  i n  the  case of M r .  Carr ,  he was not  r e a l l y  using any 
d e t e c t o r  ins ide .  I t  was simply t h e  emission from t h e  h o t  spot .  
D r .  Samaras? 
Samaras: There i s  one hangup with t h e  duplex technique, and t h a t  i s  you need 
a t  least 5 t o  10 seconds f o r  your i n t e g r a t i o n  time on your radiometer.  But, 
I th ink t h a t ,  on t h e  order  of low-hertz duplexing, microseconds i s  a l i t t l e  
b i t  too f a s t .  But, I th ink t h a t ,  on the  order  of low h e r t z ,  you could 
probably handle it simply because of  the  heat - t ransfer  c h a r a c t e r i s t i c s  of t h e  
body. 
Carr: Yes, you could. Actual ly,  you would be running b a s i c a l l y  CW f o r  a 
longer period of time, and then you would switch over and sense because you 
could c e r t a i n l y  duplex with long time dura t ions  on t h e  heat ing  and s h o r t  
t i m e  du ra t ions  on t h e  sensing and g e t  around it. It i s  a very good po in t .  
Singh: Well, I th ink i n  add i t ion  t o  microwave, both f o r  heat ing  and f o r  
sensing,  some repor ted  c l i n i c a l  s t u d i e s  seem t o  have used RF power, o r  
frequency i n  t h e  range of a few 1 0 ' s  of megahertz. I th ink ,  i f  you a r e  doing 
t h a t ,  then you have a way of handling the  problem, even with t h e  thermo- 
couples,  of t h e  temperature measurement. With t h e  RF cu r ren t ,  f o r  example, 
you do n o t  have t h e  problem of in te r fe rence  of t h e  electromagnetic f i e l d  
with t h e  d e t e c t o r  because you can have t h e  f i e l d  d i r e c t i o n  normal t o  t h e  
conductor length.  And, i f  you do have t h a t  simultaneous readout  from t h e  
thermocouple, then you could use a closed loop and maintain t h e  temperature 
you want. 
Carr: It i s  very d i f f i c u l t  when you have d i spe r s ion ,  p a r t i c u l a r l y  i n  a com- 
p lex  s t r u c t u r e  l i k e  t h e  human body, t o  t r y  t o  maintain or thogonal i ty  of t h e  
de tec t ing  device. Dispersions i n  these  media a r e  very cbmplicated. It i s  
not  l i k e  radar  i n  f r e e  space, where it i s  reasonably homogeneous. The body 
i s  not.  
Singh: I th ink you a r e  q u i t e  r i g h t ,  bu t  we d e l i b e r a t e l y  use RF cu r ren t .  We 
j u s t  use  two e lec t rodes  across  t h e  t e s t  subjec t .  The only problem i s  t h e  
heterogenei ty  of t h e  medium. 
Carr: The lower t h a t  you a r e  forced .LO go on frequency, t h e  more d i f f i c u l t  
it i s  t o  focus because most important of al1,you a r e  looking f o r  s p a t i a l  
r e so lu t ion .  
Singh: You a r e  r i g h t .  It i s  not-focusing;  it i s  simply plugged. It con- 
sists of j u s t  two e lec t rodes .  The RF c u r r e n t  provides a c t u a l l y  r e s i s t i v e  
heat ing.  
Carr: That i s  cor rec t .  Okay. 
Singh: Well, a r e  t h e r e  any more comments? 
Harrison: About t h e  u l t r a s o n i c  thermometry, I am under t h e  impression t h a t  
i f  I wanted t o  ask ques t ions  about t h a t ,  I c a l l  up P a t  Lele a t  MIT. Is any- 
one bes ides  him doing any work? I would l i k e  t o  know. 
Singh: Well, I suppose D r .  Atkinson might address t h a t .  I do n o t  know 
personally.  
Atkinson: I do no t  know i f  P a t  Lele i s  doing any work i n  u l t r a s o n i c  
tomography f o r  temperature measurement. I do know t h a t  t h e r e  was a group a t  
the  Mayo Foundation doing t h i s .  John Greenleaf and a fe l low by t h e  name of 
Johnson were involved. I am t r y i n g  t o  r e c a l l  h i s  f i r s t  name. Johnson has a 
5-year ca ree r  development award from t h e  National Cancer I n s t i t u t e ,  and he 
i s  a t  Utah r i g h t  now working on t h e  techniques. They s p l i t  o f f  i n t o  two 
groups, one a t  Mayo and t h e  o the r  a t  t h e  Utah Department of Bioengineering. 
Singh: I th ink  one add i t iona l  advantage of  t h e  sound wave would be t h a t  it 
would be a l o t  e a s i e r  t o  focus -- much e a s i e r  than,  f o r  example, t h e  micro- 
waves. Yes, D r .  Regelson? 
Regelson: A s  I mentioned e a r l i e r ,  t o  my knowledge t h e  b igges t  c l i n i c a l  
program t h a t  I know of  i n  ul trasound i s  a t  Bowman-Gray i n  Winston-Salem. 
The Reynolds people, t h e  tobacco people,  have given them a very fancy u l t r a -  
sound machine, which has been i n  c l i n i c a l  t e s t s  f o r  a t  l e a s t  6 years .  I was 
on a p r o j e c t - s i t e  v i s i t  t h e r e ,  and it i s  being a c t i v e l y  used. But, what has 
happened wi th  it, I do n o t  know. I do n o t  keep up with t h a t  l i t e r a t u r e .  
Singh: Was it p a r t  of acous t i c  holography? Was t h a t  machine used f o r  
holography, a s  such, o r  was it f o r  hyperthermia? 
Regelson: To my knowledge, a s  I r e c o l l e c t  it, it was the  ul trasound i t s e l f  
t h a t  was given s p e c i a l  v i r t u e s .  Some years ago I remember t h e  Germans were 
using ul trasound i n  combination with radiotherapy and claiming t h a t  they 
were focusing ul trasound i n  head and neck tumors, f o r  example. They g o t  an 
improved the rapeu t i c  d i f f e r e n t i a l .  This was f e l t  t o  r e l a t e  no t  s o  much, a s  
I r e c a l l ,  t o  hea t ,  b u t  t o  blood flow, increased hyperemia, whichCof course, 
could have some r e l a t i o n .  But, the re  is  an i n t r i n s i c  mystique t o  ul trasound,  
independent o f  t h e  f a c t  t h a t  it r a i s e s  temperature. 
Singh: Well, t h e r e  is ,  i n  add i t ion  t o  j u s t  t h e  temperature r i s e  associa ted  
with the  incidence of ul trasound,  t h a t  nonthermal e f f e c t  which i s  a l i t t l e  
more marked with t h e  ul trasound.  The nonthermal e f f e c t  t h a t  we have heard 
e a r l i e r  today i s  more marked, more of a problem, wi th  the  ul trasound than it 
i s  with t h e  microwaves, o r  any o t h e r  E&M form of r a d i a t i o n .  Is t h a t  no t  
co r rec t?  
Regelson: I would j u s t  l i k e  t o  g e t  t o  know t h a t  guy who was playing the  
g u i t a r  and g o t  a l l  those cockroaches and mice t o  leave! Do you remember 
t h a t ?  
Singh: They were probably f r ightened away. W e l l ,  temperature measurement 
i s  c e r t a i n l y  a challenging problem. A t  Langley we were approached by t h e  
l o c a l  medical community, the  Eastern Virgin ia  ~ e d i c a l  School and MCV, t o  s e e  
i f  some of t h e  NASA technology could be  t r a n s f e r r e d  t o  he lp  o u t .  I th ink  w e  
have a couple of groups a t  Langley. There a r e  r ep resen ta t ives  of both t h e  
groups here ,  a s  a matter  of f a c t ;  they a r e  Ed Germain and Richard Couch. 
They a r e  s e t t i n g  up a closed-loop system which uses RF heating.  And, I 
suppose t h e  idea  t h e r e  i s  t o  be a b l e  t o  maintain a cons tant  temperature, o r  
d i a l  any temperature you want, f o r  any length  of time you want. Also, you 
can probably p u t  s i x ,  seven, o r  more animals a t  one time i n t o  t h e  i n s i d e  t h a t  
encloses where you a r e  t r y i n g  t o  maintain a high temperature, o r  where you 
a r e  passing a cu r ren t .  I n  add i t ion  t o  t h a t  I th ink  we a l s o  have t h i s  c o n t r a c t  
I r e f e r r e d  t o  wi th  Microwave Associates,  Inc. I do no t  know i f  t h a t  is  i n  
e f f e c t  a l ready,  o r  not .  I th ink some of t h e  NASA technology can he lp  ou t ,  
and a t  Langley we a r e ,  indeed, cooperating a s  much a s  we can. Cer ta in ly  t h e  
use of microwave radiometers can help.  We have had Skylab and Nimbus 5, and 
I suppose i n  these  programs w e  developed t h e  radiometers.  And, I th ink  we 
a r e  c e r t a i n l y  w i l l i n g  t o  lend one t o  Microwave Associates.  So, i n  add i t ion  
t o  t h a t  promise, I do no t  know what e l s e  I can t e l l  you. Perhaps, yod w i l l  
r a i s e  t h e  ques t ion  of  what type of h e l p  you can g e t  from u s ,  and we s h a l l  see  
i f  we can come up wi th  some answers. I can assu re  you t h a t  we s h a l l  g ive  it 
considera t ion .  A r e  t h e r e  any problems? D r .  Atkinson? 
Atkinson: May I r a i s e  the  quest ion of  how you a r e  going t o  know where t h e  
microwave thermal r a d i a t i o n  i s  coming from i n t e r n a l l y  from t h e  c l i n i c a l  sub- 
j e c t  o r  the  animal? This has been a r e a l  impediment t o  microwave thermometry, 
t o  my knowledge. The f a c t s  of  extremely poor s p a t i a l  r e s o l u t i o n  due t o  
i n t e r n a l  s c a t t e r i n g ,  heterogeneous organs, bones, and long wavelength make 
t h e  p rec i s ion  -- even i n  two dimensions, l e t  a lone  i n  t h e  t h i r d  dimension, o r  
along t h e  Z a x i s  -- a s  t o  where it i s  coming from d i f f i c u l t .  Even i n  two 
dimensions, l o c a l i z i n g  where t h e  r a d i a t i o n  i s  coming from i s  d i f f i c u l t .  I 
be l i eve  these  a r e  fundamental basic-research problems t h a t  should be under- 
taken. It i s  w e l l  t o  t a l k  about poss ib le  f u t u r e  app l i ca t ions  of t h i s  t o  
something l i k e  hyperthermia, bu t  I do no t  th ink t h a t  t h e  beginnings have even 
been made. There a r e  many fa l l -back pos i t ions .  The t o o l  might be u s e f u l  i f  
it were developed f o r  t i s s u e  cha rac te r i za t ion ,  f o r  var ious  screening 
d iagnos t i c  procedures, o r  f o r  a very n ice  adjunct  t o  d iagnos t i c  radiology. 
But, I personal ly  f e e l  t h a t  it i s  a l i t t l e  f a r  down t h e  l i n e  f o r  u s  t o  t a l k  
about microwave radiometry i n  hyperthermia. 
Singh: Well, I th ink you do have a good comment. But, i s  it not  a l ready i n  
use,  f o r  example, a t  Falkner Hospital ,  where they a r e  using 1.30313 giga- 
he r t z?  I th ink t h e i r  s p a t i a l  r e so lu t ion  i s  l e s s  than a centimeter .  And, 
they claim t h a t  they can see  a tumor t h e  s i z e  of about 1-centimeter diameter.  
I th ink maybe t h a t  is one o f  the  goa l s  t h a t  we have i n  connection with what 
we a r e  going t o  do. 
Carr: The work a t  Falkner Hospital  has mostly been done a t  1.7 g igaher tz  and 
3 gigaher tz .  They a r e  now considering going t o  a higher frequency. There 
a r e  t r adeof f s  between s p a t i a l  r e so lu t ion  and frequency. A s  you go higher i n  
frequency and approach the  in f ra red  frequency, of course,  the  emission from 
t h e  t a r g e t ,  o r  from t h e  tumor, becomes g rea te r .  For good s p a t i a l  r e so lu t ion  
a t  the  higher frequencies,  however, t h e  depth of the  tumor below t h e  surface  
would push us  toward t h e  lower frequencies.  So, you do have some t r adeof f s .  
Now, t h e  f a c t  i s  t h a t  you may not be able t o  g e t  a l l  t he  advantages, and you 
w i l l  have t o  make some t r adeof f s .  You may not  be measuring t h e  temperature 
of t h e  tumor i t s e l f ;  b u t  you may be measuring it a t  some d i s t ance  away from 
t h e  tumor, which is c e r t a i n l y  c l o s e r  than being a t  t h e  surface .  You w i l l  be 
ab le  t o  g e t  a d e f i n i t i o n  of where t h e  tumor is.  And, I th ink ,  once t h a t  you 
have learned t o  l o c a t e  t h e  tumor t h i s  way, you w i l l  a l s o  know more about how 
t o  apply hea t  t o  the  tumor because it should be t h e  reverse  of what you have 
learned.  
Singh: Well, t h a t  i s  t r u e ,  yes. But, I th ink i n  answer t o  t h a t  quest ion of 
how do we l o c a l i z e  it, it i s  a very s t rong funct ion  of t h e  temperature, t h e  
microwave emission from t h a t  po in t .  And, of course,  I th ink it w i l l  
c e r t a i n l y  be t h e  h o t t e s t  p a r t  t h a t  w i l l  e m i t  t h e  most. By simply scanning 
across ,  you should be  ab le  t o  sense the  spo t  where the  tumor i s .  You a r e  
no t  going t o  be able  t o  l o c a l i z e  it, I agree ,  b u t  you can spo t  it below t h e  
surface ,  a t  l e a s t .  D r .  Regelson? 
Regelson: Again, I wish somebody would t e l l  me why the  mice's t a i l s  f a l l  
of f  i n  a s soc ia t ion  with diapulse!  What i s  t h e r e  about t h e  base of t h e  t a i l  
t h a t  c r e a t e s  a burn? 
Singh: I do n o t  know, b u t  d id  you have standing waves of some s o r t ?  
Regelson: I do not  know. It i s  a t a i l  wave, whatever it is: But, another  
i n t e r e s t i n g  th ing  r e l a t e s  t o  what I was t a l k i n g  t o  Don Cone about. Don Cone, 
of course, i s  i n t e r e s t e d  i n  sodium re la t ionsh ips .  S a l t  concentrat ion i n  
tumors i s  very high. Is t h e r e  anything about microwave i n  r e l a t i o n  not  only 
t o  the  water content  which people have ta lked about b u t  a l s o  t o  th ings  l i k e  
sodium concentrat ion? Can these  be f a c t o r s  t h a t  could be r e l a t e d  t o  manipu- 
l a t i o n ?  O r ,  could t h i s  explain d i f f e r e n t i a l  e f f e c t s ?  
Singh: W e l l ,  I do no t  know. But, l e t  me give  you an analogy. I f  you have 
j u s t  a c i r c u i t  element and you make a small  break t h e r e  somewhere, the re  i s  
i n t e r m i t t e n t  sparking t h e r e  and t h e  spark hea t s  the  most. Are you having 
some such th ing  a t  t h a t  p o i n t  where t h e  t a i l  j o ins  t h e  body? Do you have, 
f o r  example, a sudden change i n  t h e  impedance, o r  a sudden change i n  the  
r e s i s t a n c e ,  the re  due t o  ion ic  concentrat ions? Don? 
D. Cone: Not t o  my knowledge. 
Regelson: The only th ing you have go t ,  o f  course,  a t  t h a t  po in t  i s  t h a t  t h e  
t a i l  ve r t eb ra  become continuous with t h e  p e l v i s ,  and you have go t  one b i g  
bone, whereas before you had small sepa ra te  bones. 
Singh: I think t h a t  before can r ea l l y  answer t he  question, we sha l l  have 
t o  look a t  the whole problem. We s h a l l  have t o  look a t  the actual  layout 
and see  what i s  involved. I do not think t h a t  I can off-hand answer the  
question. Maybe t h a t  i s  going t o  be a l i t t l e  d i f f i c u l t .  In view of the  
f a c t  t h a t  the temperature measurement was one of the ho t t e s t  problems, I am 
ra ther  g r a t i f i e d  t o  see t h a t  you do not have the  problem, t h a t  you a r e  
s a t i s f i e d  with the things you have, o r  t h a t  you know your own bag. 
Shaeffer: I was kind of surprised t h a t  no one brought up anything about 
using l iqu id  c rys t a l  type measurements. That might be the  way t o  go. We 
have t o  move along here. The next topic  f o r  discussion i s  Prec l in ica l  
Experiments, and t h i s  session w i l l  be moderated by D r .  T i m  Merz from MCV. 
Session 3: P r e c l i n i c a l  Experiments 
Moderator: Timothy Merz 
Merz: Since I have no p r e c l i n i c a l  d a t a  to  present ,  I am obviously t h e  l o g i c a l  
person t o  moderate t h i s  session.  A t  t he  meetings i n  Wisconsin, t h e r e  w a s  
considerable t i m e  spent  discussing to lerance  t o  heat.  I have not  heard t h a t  
mentioned. I would be i n t e r e s t e d  i n  hearing more about tha t .  Also, pecul- 
i a r l y  enough, everybody is  t a lk ing  about Hol t ' s  experiments with hea t  due t o  
434-megahertz microwave rad ia t ion ,  H e  w a s  very c a r e f u l  t o  po in t  o u t  i n  
Wisconsin t h a t  he d i d  no t  th ink hea t  had anything t o  do with h i s  r e s u l t s .  
He a l s o  s a i d  t h a t  e s s e n t i a l l y  he gave very low orde r s  of r ad ia t ion ,  l i k e  600 
rads,  f o r  the  t o t a l  treatment; and he d i d  not th ink he r a i s e d  t h e  t e m ~ e r a t u r e  
p a s t  3g0 C, a s  I r e c a l l .  H e  thought t h e r e  was a tremendous component from 
the  microwave r a d i a t i o n  i t s e l f  and t h a t  434 megahertz was the  magic number. 
I would a l s o  l i k e  t o  hear  anything from anybodv on t h i s ,  Yes? 
Atkinson: Nith regard t o  Hol t ' s  paper, I chairef! h i s  sess ion  i n  fi:isconsin, 
and I a l s o  at tended a p resen ta t ion  he rr,ade a t  A i r l i e  House. I would l i k e  t o  
po in t  o u t  t h a t  h i s  evidence t h a t  he is  deal ina  with a nonthermal e f f e c t  i s  
based exclus ively  upon t h e  f a c t  t h a t  he nacks t h e  p a t i e n t  i n  i c e  and p laces  
the  434-megahertz antenna around t h e  p a t i e n t  and then, when he t akes  the  
antenna away and looks with an I R  thermograph, he f i n d s  t h a t  the  sk in  is  
indeed cold.  Now, t h i s  is  a technique t h a t  has been widely used t o  prevent 
sk in  burning with deep-t issue heating. This  is  f a r  from beinq evidence t h a t  
he has not  heated the  t i s s u e .  I th ink t h i s  would be an exce l l en t  way t o  hea t  
the  t i s s u e  without heat ing the  skin. So, I do not  know t h a t  we can r e a l l y  con- 
clude t h a t  D r .  Halt has observed a nonthermal e f f e c t ,  o r  t h a t  he has any 
evidence t h a t  he is looking a t  a nonthermal e f f e c t .  
Merz: I do no t  th ink  t h e r e  is any doubt about t h a t ,  bu t  t h a t  is d e f i n i t e l y  
what he reported a t  t h e  t i m e .  There is  a p o s s i b i l i t y ,  which has been mentioned 
severa l  t imes by my colleague,  D r .  Wilson, t h a t  t h e  damage t h a t  w e  a r e  looking 
a t  i n  terms of what we c a l l  enhancement of r ad ia t ion  damage by hyperthermia 
is@ indeed, t o  some ex ten t  an enhancement of damage, r a t h e r  than an i n h i b i t i o n  
of r epa i r .  I th ink most of u s  a r e  s tuck on the  r e p a i r  c a p a b i l i t y  change, and 
no t  on t h e  damage. That is another t h i n g  t h a t  one of you might want t o  t a l k  
about, 
Regelson: One of t h e  t h i n q s  t h a t  I was impressed with about Wilson" presen- 
t a t i o n  is t h e  f a c t  t h a t  he g o t  a p ro tec t ive  e f f e c t ,  o r  t h a t  he might have, 
r a t h e r  than a s y n e r g i s t i c  e f f e c t ,  I am reminded of Emanuel F a r b e r ' s  work with 
a lky la t ing  agents  and cyclohexamide pretreatment i n  rodents ,  where he pro- 
t e c t e d  t h e  i n t e s t i n a l  epi thel ium by i n t e r f e r i n q  with p ro te in  synthes is ,  
chemotherapeutic l e t h a l i t y  t o  t h e  gut  r e q u i r e s  RNA and pro te in  syn thes i s ,  and, 
i f  you impede it with something l i k e  cycloheximide, you could p r o t e c t  aga ins t  
ni trogen mustard and, a s  I r e c a l l ,  actinomycin D. I cannot remember which 
o t h e r  chemotherapeutic agents  were involved, bu t  you prevent  slough-off of t h e  
i n t e s t i n a l  mucosa by blocking p ro te in  synthes is .  So, it i s  ~ o s s i b l e  t h a t  you 
have some s o r t  of  r e l a t i o n s h i p  Like t h i s  operat inq.  Has anybody s tudied  f r e e  
r a d i c a l  formation i n  a s soc ia t ion  with heat? 
Merzr I have heard t a l k  of it. I have no t  read any papers,  though, 
Regelson: A f e l low by t h e  name of S l a t e r  i n  London and a number of o t h e r  
people have followed through on t h i s  th ins ,  The concept of t i s s u e  damage a s  a 
funct ion  of f r e e  r a d i c a l  formation i s  a genera l  phenomenon i n  biology t h a t  i s  
suddenly coming i n t o  i ts  own, There a r e  a number of p e o ~ l e  now who a r e  
administering f r e e  r a d i c a l  scavengers and ant ioxidants ,  They claim t h a t  they 
a r e  p ro tec t ing  t h e  myocardium from ischemia and p ro tec t inq  t h e  b ra in  from 
t o t a l  ischemias They u t i l i z e  agents  l i k e  dimethyl sulfoxide,  which is a f r e e  
r a d i c a l  scavenger, 
Merz: About t h e  p ro te in  synthes is ,  I th ink t h e r e  is an enormous amount of 
evidence t h a t ,  i n  some systems, you tend t o  p r o t e c t  aga ins t  damage by inh ib i -  
t i n g  p r o t e i n  synthes is .  Th i s  happens i f  you a r e  deal ing  with a p o t e n t i a l l y  
l e t h a l  dose of r ad ia t ion ,  o r  i f  you a r e  deal ing  with an enzyme which tends  t o  
c u t  th ings  out  severe ly  when i t s  t r y i n g  t o  open up f o r  r e p a i r ,  But, t h e r e  i s  
a l s o  an enormous amount of d a t a  which would t e l l  you t h a t ,  under o t h e r  circum- 
s tances ,  you g e t  anything b u t  p ro tec t ion ,  You g e t  considerable damage by 
c u t t i n g  o u t  p ro te in  syn thes i s  because, when you c u t  ou t  p r o t e i n  synthesis ,  you 
c u t  out ,  i n  many ins tances ,  t h e  polymerases t h a t  a r e  going t o  r e p a i r  t h e  
damage. ~nybody  e l s e ?  Jim? 
Shaeffer:  I was a l i t t l e  l a t e  i n  a r r iv ing  this r o r n i l g ,  and I d id  not hear 
a l l  of what D r .  Baker had t o  say, I was wondering wlrether a few vears  back 
somebody might have r e f e r r e d  t o  hyperthermia a s  a poor man's LET source. 
I know t h a t  Gene Robinson had done some work alonq these  l i n e s .  I was 
wondering i f p  s ince  we have D r .  Harrison i n  the  audience, he might comment on 
the  oxygen enhancement r a t i o  using hyperthermia, 
Harrisonr D r .  Baker showed the  reduction OER a s  t h e  t e m ~ e r a t u r e  goes up, and 
t h a t  was t h e  d a t a  of Robinson, I think.  I t  has a l s o  been shown by some o the r  
people. That does seem t o  be cheaper than a p i  meson qenerator .  
shaeffer :  I t  is  cheaper by q u i t e  a few d o l l a r s ,  a t  l e a s t :  
Merz: It is cheaper by about t en  mi l l ion  do l l a r s !  
Harrison: On t h e  o t h e r  hand, i s  OER r e a l l y  important i n  c l i n i c a l  r a d i a t i o n  
therapy? 
Merz: That  i s  another  good Cluestion. 
Harrison: I do not know what i s  happening with t h e  neutron t r i a l s ,  and I do 
no t  know i f  t h a t  i s  going t o  be t h e  b e s t  reason f o r  hyperthermia, o r  not .  
Regelson: Has anybody looked a t  heat  p r o t e c t i v e  agents ,  l i k e  people look a t  
an t i f r eeze .  I r e c a l l  some paperl bu t  I have no t  kept up with them, i n  regard 
to calcium t i s s u e  content  r e f l e c t i n g  hea t  death.  I am a l s o  thinking o f  some 
of t h e  work t h a t  Cornforth reported yea r s  ago on hea t  shock, where you t ake  
blood c e l l s ,  f r e e z e  them, thaw them, and then measure the  h e m l y s i s ,  1 know 
the re  i s  l i t e r a t u r e  the re ,  I wonder whether anybody has looked t o  f i n d  t h e  
p re - fa t ty  acid,  l ipopro te in  r a t i o  i n  t h e  membrane t h a t  seems t o  qovern t h i s .  
Some people have made membrane models of t h i s  kind. Does anybody know any- 
th ing about t h i s ?  This  i s  becoming increas ingly  important, For example, 
complement antibody cell l y s i s  i s  inverse ly  r e l a t e d  t o  f a t t y  ac id  incorpora- 
t ion.  I f  the  f a t t y  ac id  i n c o n o r a t i o n  p r o t e c t s  from complement cel l  damage, 
then it is q u i t e  p o s s i b l e  t h a t  protease  l e t h a l i t y ,  o r  l i p a s e  l e t h a l i t y ,  
p r o t e c t s  t h e  c e l l  surface.  could t h e  s t a b i l i t y  of t h e  surface  t o  hea t  r e f l e c t  
on something l i k e  t h i s ?  Is anybody working with models of t h i s  kind? O r ,  has 
anybody reviewed t h e  l i t e r a t u r e  r e l evan t  t o  t h i s ?  
Singhs How does hyperthermia compare with o t h e r  forms of t reatment l i k e  f a s t  
neutron, o r  pion,  therapy? Does it match, f o r  example, pion therapy? 
Merz: Well, I do no t  r e a l l y  understand t h e  quest ion,  You can g e t  su rv iva l  
curves with hyperthermia, i f  you want t o  take  t h e  temperature up enough t o  
e s s e n t i a l l y  where t h e  to ie rance  e f f e c t  can be seen. But, when you a r e  t a lk ing  
about t h e  enhancement of radiotherapy and rad ia t ion  damage by hyperthermia, 
these  a r e  d i f f e r e n t .  You cannot compare t h e  two. 
Shaefferr W e  come now t o  the  l a s t  segment o f  the  open-discussion p a r t  o f  t h i s  
symposium, C l i n i c a l  T r i a l s .  This  sess ion  w i l l  be moderated by D r .  William 
Constable from t h e  Universi ty of Virgin ia  Medical School, 

Session 4 t C l i n i c a l  T r i a l s  
Moderator: William C. Constable 
Constable: A l l  I have heard i s  t h a t  w e  r e a l l y  do n o t  know what we a r e  doing 
with hyperthermia. I am r e a l l y  no t  sure  whether t h e r e  i s  even a place f o r  
c l i n i c a l  t r i a l s  y e t ,  l e t  alone a p lace  f o r  using it. Although, i f  you look 
back, you r e a l i z e  t h a t  t h e  r a d i c a l  mastectomy was introduced without a 
s i n g l e  c l i n i c a l  t r i a l ,  and a l s o  t h a t ,  wi th in  about 6 months a f t e r  discovery,  
X-rays were being used the rapeu t i ca l ly  without a c l i n i c a l  t r i a l .  Perhaps, 
we should consider  whether t h e r e  i s  any place  f o r  using hea t  and r a d i a t i o n ,  
empir ica l ly  on the evidence t h a t  we have a t  t h e  p resen t  time. I f  so ,  what 
would t h i s  s i tua , t ion  be? Now, D r .  Baker has been involved i n  some of t h i s  
work i n  San Francisco. I was wondering i f  he would mention some of the  
experience t h a t  they have had the re  with t r e a t i n g  l e s i o n s  with h e a t  and 
radiotherapy i n  a con t ro l l ed  c l i n i c a l  t r i a l .  
Baker: There was a c l i n i c a l  t r i a l ,  admit tedly not  q u i t e  con t ro l l ed  and n o t  
e n t i r e l y  wi th in  t h e  boundaries of t h e  RTOG protocol ,  conducted i n  
San Francisco. The idea  was t o  i n v e s t i g a t e  f e a s i b i l i t y .  One aim was t o  f ind  
ou t  i f  it was p r a c t i c a l ,  i n  f a c t ,  t o  set  up i n  a p r a c t i c a l  r a d i a t i o n  therapy 
department a c l i n i c a l  hyperthermia program. There were a couple of quest ions 
we needed t o  answer. Not so  much the  b io log ica l  consequences, a s  those I 
th ink we can deduce from the  amount of  l i t e r a t u r e  p resen t ly  ava i l ab le ,  from 
p a s t  experience, from p r e c l i n i c a l  t r i a l s ,  from animal s t u d i e s ,  and so on. 
But, was t h e r e  a p r a c t i c a l  po in t  t o  t h i s  i n  t h e  sense of cos t -benef i t  t o  t h e  
department? To begin wi th ,  the re  was t h e  i n i t i a l  ou t l ay  f o r  t h e  kind of 
equipment and f a c i l i t i e s  t h a t  were needed. And, t h a t  represents  a f a i r l y  
l a rge  d o l l a r  t a g ,  although not  q u i t e  comparable t o  t h a t  of a new l i n e a r  
acce le ra to r .  For each treatment,  you a r e  ty ing up a t reatment room between 
16 and 2 hours. You a r e  a l s o  ty ing up a fu l l - t ime,  highly paid technic ian  
f o r  t h a t  same length  of time, a t  l e a s t .  You a r e  ty ing  up physician time by 
a f a c t o r  of f i v e ,  compared t o  a conventional r a d i a t i o n  therapy treatment.  
You a r e  then confronted with a l l  t he  medical l e g a l  problems associa ted  with 
the  use of t h i s  modality. There a r e  a l l  t he  problems associa ted  with consent 
forms and whether o r  no t  they a r e  v a l i d  a t  a l l .  There i s  t h e  ques t ion  of who 
i s  responsib le  l e g a l l y .  A l l  t h e s e  th ings  have been mentioned b r i e f l y  by 
D r .  Atkinson; and they a r e  horrendous problems, when you happen t o  be t h e  
person whose name i s  on t h e  l i n e .  There i s  a l s o  t h e  budget problems i n  
terms of nurses ,  nurse time, and usable suppl ies .  And, i f  any of you a r e  
a n t i c i p a t i n g  g e t t i n g  i n t o  t h e  hyperthermia business i n  a l o c a l  r a d i a t i o n  
therapy department, then I suggest  you very c a r e f u l l y  cost-account the  
program before  you g e t  it s t a r t e d .  We have done t h a t ,  and t h e  bottom l i n e  
g e t s  t o  be q u i t e  l a rge .  
Constable: Don, do you no t  th ink ,  however, t h a t  we have enough c l i n i c a l  
information now t o  suggest t h a t  it could be used i n  very s p e c i f i c  
circumstances, such a s  i n  the  treatment of s u p e r f i c i a l  masses t h a t ,  perhaps, 
have been unsuccessful ly t r e a t e d  previously and f o r  which the re  a r e  no o t h e r  
t reatments ava i l ab le?  
Baker: There i s  no questioIf, i n  my mind, about i t s  e f fec t iveness .  You know, 
1 have seen some r a t h e r  remarkable regress ions  of l o c a l  tumors t h a t  have been 
r e f r a c t o r y  t o  a l l  t h e  conventional modal i t ies .  I have seen them very suc- 
c e s s f u l l y  t r e a t e d  by small doses of r a d i a t i o n  and hyperthermia, o r  even by 
hyperthermia alone. So, t h e r e  is  c e r t a i n l y  a p lace  f o r  it. I th ink t h e  
quest ion i s  not  r e a l l y  t h a t ;  b u t ,  r a t h e r ,  can w e  a f fo rd  t o  use i t ?  I t  i s  not  
a quest ion of i s  it e f f e c t i v e ,  o r  can we use i t ?  We c e r t a i n l y  can use  it. 
But, can we a f f o r d  t o  use i t ?  And, t h a t  i s  t h e  bottom l i n e  t h a t  involves 
both the  l e g a l  a spec t s ,  a s  w e l l  a s  t h e  time and c o s t .  
Constable: Cer ta in ly ,  we have been approached by community h o s p i t a l  radio-  
therapy departments f o r  advice on how they can s e t  up t h e i r  hyperthermia 
programs. So, t h e  information t h a t  has been g e t t i n g  i n t o  t h e  p ress  from 
exuberant M . D . ' s  who have been researching i n  t h i s  f i e l d  has had i t s  e f f e c t .  
And, these  people a r e  now f e e l i n g  they want t o  g e t  i n t o  t h i s  a rea ,  which is  
e s s e n t i a l l y  s t i l l  a research a rea .  With regard t o  t h e  documentation of 
p a l l i a t i v e  responses,  t h i s  i s  very d i f f i c u l t  i n  radiotherapy.  I a m  not  even 
su re  i f  you can run a con t ro l l ed  t r i a l  i n  t h i s  a rea .  We have, I t h i n k ,  one 
p a t i e n t  who i s  s o r t  of a con t ro l .  The p a t i e n t  had a melanoma; we t r e a t e d  it 
with conventional l e v e l s  of r a d i a t i o n .  I t  d id  not  respond a t  a l l  t o  t h e  
radiotherapy.  Six  months l a t e r ,  when D r .  Baker a r r ived ,  w e  t r e a t e d  it with 
another  12 hundred o r  so  p lus  hea t ;  and t h e  th ing  j u s t  melted away. That i s  
a r a t h e r  su rp r i s ing  th ing  t o  happen. I do n o t  know how t h a t  could b e .  
explained,  except  on t h e  b a s i s  t h a t  h e a t  does have an e f f e c t .  D r .  Atkinson? 
Atkinson: With regard t o  t h e  ques t ion  of t h e  c o s t  of research  i n  hyper- 
thermia, I th ink t h a t  t h i s  i s ,  indeed, a r e a l  problem. We, i n  generat ing 
t h e  RTOG protocol ,  s e r ious ly  looked a t  j u s t  what information we could g e t  
f o r  t h e  minimum c o s t  and minimum development. The h ighes t  p r i o r i t y ' t h a t  we 
could e s t a b l i s h  was t o  determine whether o r  n o t  the re  was a therapeut ic  
advantage t o  t h e  use  of h e a t  i n  conjunction with radiotherapy.  For t h i s  
reason,  we chose t o  l i m i t  t h e  p a t i e n t  populat ion t o  those  p a t i e n t s  having 
s u p e r f i c i a l  l e s ions .  With regard t o  t h e  instrumentat ion required t o  produce, 
monitor, and con t ro l  the  heat ing ,  it appeared t h a t  f o r  s u p e r f i c i a l  l e s i o n s  
the  24-gigahertz r a d i a t i o n ,  with a penet ra t ion  depth of only 1 t o  2 
cent imeters ,  would be  adequate. And, a l s o ,  t h i s  l e n t  i t s e l f  t o  a c l i n i c a l  
t r i a l  with a minimum r i s k  associa ted  with deep bone heat ing.  We were r a t h e r  
s k e p t i c a l  about t h e  s a f e t y  of using more penet ra t ing  rad ia t ion .  And, a l s o ,  
we considered the  f a c t  t h a t  2%-gigahertz machines a r e  commonly a v a i l a b l e  i n  
hosp i t a l s .  The c o s t  of the  instrumentat ion among t h e  var ious  p a r t i c i p a n t s  i n  
the  RTOG protocol ,  I be l i eve ,  came t o  about $5,000 per  organizat ion.  You a r e  
q u i t e  r i g h t ,  however, t h a t  t h i s  i s  a labor-intensive method. The labor  c o s t s  
about $50,000 t o  $75,000 per  man year .  We f e l t  t h a t  it would probably 
involve the  fu l l - t ime work of a t  l e a s t  1% men t o  execute t h e  protocol  t h a t  we 
had ou t l ined .  But, it i s  research  t h a t  i s  expensive, not  p a r t i c u l a r l y  hyper- 
thermia research.  The instrumentat ion i s  n o t  t e r r i b l y  expensive. We have 
been t a l k i n g  about some very exo t i c ,  secondary and t e r t i a r y ,  research  goals  
t h a t  might be associa ted  with hyperthermia, f a r  down the  l i n e .  I wonder 
whether they a r e  r e a l l y  e s s e n t i a l  t o  the  inves t iga t ion  of hyperthermia. 
Sure, they a r e  i n t e r e s t i n g  b io log ica l  and c l i n i c a l  inves t iga t ions ,  bu t  t h e i r  
relevance t o  hyperthermia i s ,  i n  my-mind, sometimes very o f t e n  i n  quest ion.  
Hyperthermia, I th ink ,  can be used a s  a good f r o n t  f o r  o t h e r  research  
a c t i v i t i e s .  There is  absolute ly  nothing wrong with t h i s ,  a s  long a s  we 
recognize t h i s  t o  be what it is. 
Constable: Do you th ink  t h a t  the re  i s  a p lace  f o r  hyperthermia i n  p a l l i a t i v e  
s i t u a t i o n s  ou t s ide  your p a r t i c u l a r  c l i n i c a l  t r i a l s ?  
Atkinson: W e l l ,  we a r e  doing a whole-body hyperthermia c l i n i c a l  t r i a l .  We 
a r e  j u s t  terminating phase 1, which was pr imar i ly  t o  inves t iga te  toxicology, 
t o  e s t a b l i s h  the  f e a s i b i l i t y ,  t o  determine the  p a t i e n t  se lec t ion  c r i t e r i a ,  
and what n o t ,  f o r  t h e  chemotherapy t r i a l ,  which we have j u s t  undertaken. 
And, we have only done two treatments,  a s  a matter  of  f a c t .  A few weeks ago 
we s t a r t e d  on t h e  chemotherapy i n  conjunction with whole-body hyperthermia, 
so it i s  r e a l l y  too soon t o  say. We have seen some ob jec t ive  evidence of 
remission i n  t h e  whole-body hyperthermia with h e a t  alone.  I am n o t  an 
oncologis t ,  s o  I r e f e r  you t o  t h e  medical oncology branch of N C I  f o r  more 
information on t h i s .  But, we were r a t h e r  su rp r i sed  t h a t  the  hea t  alone 
apparently was e f f e c t i v e  i n  some t rea tments ,  t h a t  i s ,  a s  e f f e c t i v e  a s  it 
turned out  t o  be. 
Constable: So, i n  f a c t ,  what we a r e  saying i s  t h a t  it i s  no t  a l l  smoke. 
Maybe, the re  i s  a l i t t l e  b i t  of f i r e  under the re .  
Atkinson: Well, we a r e  hoping from t h i s  RTOG protocol  t o  answer t h i s  ques- 
t i o n  very d e f i n i t i v e l y .  That i s ,  i s  t h e r e  a d i f f e r e n t i a l  increase  i n  sus- 
c e p t i b i l i t y  t o  r a d i a t i o n  damage between tumor and normal t i s s u e ?  That i s  
t h e  major problem t h a t  w e  a r e  addressing. There a r e  14 p a r t i c i p a t i n g  uni- 
v e r s i t i e s  i n  t h i s  protocol .  We a r e  2 months i n t o  t h e  protocol  now, so we 
do no t  have any d a t a  ye t .  Let us see ,  l a s t  month t h e  p i l o t  s t u d i e s  were 
presented. These were j u s t  pr imar i ly  s t a r t -up  inves t iga t ions ,  from which 
the re  a r e  no r e a l  da ta .  I th ink t h a t  it i s  extremely important t h a t  we 
address t h i s  quest ion.  I do no t  th ink it can ever be answered by i n  v i t r o  
t i s s u e  c u l t u r e  work because, a f t e r  a l l ,  almost any s t r e s s ,  including r a i s i n g  
temperature, decreases t h e  v i a b i l i t y  of t h e  c e l l .  We can t a l k  about pH; we 
can t a l k  about CO w e  can t a l k  about n u t r i e n t  l e v e l s ;  we can t a l k  abcut any- 2 ; 
th ing  you add t o  make l i f e  uncomfortable f o r  t h e  c e l l .  The quest ion is :  
"What c o n t r o l s  can we compare it t o  i n  t i s s u e  cu l tu re?"  There r e a l l y  a r e  no t  
any. I n  animals the  tumor systems t h a t  we know the  most about a r e  the  murine 
systems, and these  animals a r e  extremely suscep t ib le  t o  t h e  e f f e c t s  of heat .  
So, w e  a r e  almost excluded from t h e  beginning from dea l ing  with these  
animals i n  an e f f e c t i v e ,  evaluable manner, such a s  i s  used i n  chemotherapy. 
If we go t o  l a r g e  animals, the re  a r e  no con t ro l l ed  tumor systems. What has 
motivated me, anyway, a t  N C I  a r e  the  var ious  semi-anecdotal c l i n i c a l  
experiences t h a t  have been appearing i n  the  l i t e r a t u r e  over the  p a s t  50 years ,  
with increas ing frequency i n  the  p a s t  10  - 1 2  years .  And, t h a t  i s  pr imar i ly  
t h e  way I have been j u s t i f y i n g  and r a t i o n a l i z i n g  the  conduct of c l i n i c a l  
t r i a l s .  We a r e  q u i t e  conservative a t  t h e  National Cancer I n s t i t u t e .  I t  was 
with g r e a t  d i f f i c u l t y  t h a t  we d i d  g e t  t h e  four protocols  t h a t  we have f o r  
hyperthermia through our var ious  committees. 
Constable: Anas, d i d  you want t o  comment on t h e  RTOG t r i a l  and hyperthermia? 
El-Mahdi: I th ink I would l i k e  t o  comment about t h e  whole i s s u e  of t h e  t r e a t -  
ment of cancer, a c t u a l l y .  There i s  a b i g  gap between t h e  b a s i c  s c i e n t i s t s  
and the  c l i n i c i a n s .  I f  it i s  going t o  be expensive and very sophis t ica ted ,  
such t h a t  you need something l i k e  10 s c i e n t i s t s  t o  t r e a t  one p a t i e n t  i n  
1 week, then f o r g e t  it. This is  t r u e  -- even i f  you a r e  going t o  cure  a l l  
cancer! I f  you a r e  n o t  going t o  have a simple instrument, f o r  t h e  c l i n i c i a n ,  
then f o r g e t  it. Do no t  waste your time now. The hyperthermia reminds me of 
the  oxygen. W e  went through t h a t  a few years  ago. Everyone was speaking 
about hyperoxygen, oxygenation of t h e  tumor, s e n s i t i v i t y ,  and so f o r t h .  But, 
once it entered  the  c l i n i c a l  f i e l d ,  it d ied  because of t h e  extens ive  t i m e ,  
e f f o r t ,  and t h e  kind of ma te r i a l  we were using. If t h e  RTOG i s  going t o  
confine i t s e l f  t o  t h e  sk in  tumors only ,  they b e t t e r  f o r g e t  about  t h a t .  W e  
a r e  n o t  i n t e r e s t e d  i n  the  s u p e r f i c i a l  l e s i o n ,  even i f  they s a i d  t h e r e  was a 
100 percent  cure r a t e  from h e a t  and rad ia t ion .  The people dying these  days 
from cancer a r e  the  people with cancer of t h e  lung, of  t h e  b r e a s t ,  of  the  
colon, of  the  deeply-seated tumor, o r  of disseminated tumors. We can cure 
the  s u s e r f i c i a l  ones. I can take  them ou t .  I can cure them by many means. 
I do n o t  need hyperthermia f o r  s u p e r f i c i a l  l e s ions .  But, i f  a p a t i e n t  comes 
i n  with a huge a x i l l a r y  mass, no one can do anything about it. So, I th ink 
we need a l i t t l e  b i t  of no t  focusing h e a t ,  bu t  focusing thinking,  with a l l  
due r e s p e c t  t o  the  soph i s t i ca ted  work coming from you researchers .  It has 
become l i k e  a fashion now. The whole country i s  going i n t o  hyperthermia. 
The whole country is  going t o  r a d i o s e n s i t i z e r s .  And, the re  i s  a very,  very ,  
b i g  gap. I th ink we a r e  dec l in ing  i n  t r e a t i n g  cancer,  no t  progressing.  
Atkinson: With regard t o  t h e  RTOG protocol ,  I q u i t e  agree t h a t  a s u p e r f i c i a l  
me tas ta t i c  l e s i o n ,  o r  tumor, is obviously t r e a t a b l e  by su rg ica l  means, o r  by 
any number of means. You say  t h a t  you would n o t  need hyperthermia f o r  t h a t .  
But, t e l l  m e ,  would you no t  l i k e  t o  know before  you t r e a t e d  a lung-cancer 
p a t i e n t ,  o r  subjected the  p a t i e n t  t o  a r i s k  of r a d i a t i o n  pneumonitis, whether 
o r  n o t  a s u p e r f i c i a l  me tas ta t i c  l e s i o n  i n  t h e  lung was suscep t ib le ,  o r  d i f -  
f e r e n t i a l l y  suscep t ib le ,  t o  hyperthermia? 
El  Mahdi: Well, you yourself  s a i d  t h a t  i n  t h e  l a s t  50 years  the re  has been 
a l o t  of d a t a  i n  t h e  l i t e r a t u r e  which i n d i c a t e s  t h a t  h e a t  by i t s e l f  can cure  
some kinds of cancer. There a r e  many th ings  I want an answer t o .  For t h e  
s c i e n t i s t s ,  can you i n  a simple way hea t  a deeply sea ted  s t r u c t u r e ?  I hear 
people speaking about one by one mi l l imeter ,  and a l l  t h a t .  That i s  no t  t h e  
issue!  The i s s u e  i s  a b ig  tumor down t h e r e  i n  t h e  abdomen of t h a t  human 
being, f o r  example, i n  t h e  pancreas. I do no t  know i f  I can hea t  it. We 
agree,  i n  general ,  from the d a t a  a v a i l a b l e  t h a t ,  perhaps, h e a t  by i t s e l f ,  o r  
h e a t  and chemotherapy, o r  h e a t  and r a d i a t i o n ,  may do something. We agree  
about t h a t .  But, we have n o t  solved the.problem of de l ive r ing  the  heat .  W e  
do no t  know the  e f f e c t s  of d i f f e r e n t  kinds of hea t  -- wet hea t ,  dry  hea t ,  o r  
which wavelength we a r e  going t o  use  t o  h e a t  a p a r t i c u l a r  t i s s u e .  Everyone 
i s  speaking about t h e  normal t i s s u e  i n  animals,, bu t  no one i s  speaking about 
a p a r t i c u l a r  normal t i s s u e  i n  animals, l i k e  the  lung t i s s u e .  Is t h e  e f f e c t  
t h e  same a s  i n  the  s p i n a l  cord, a s  i n  sk in ,  a s  i n  i n t e s t i n e s ,  a s  i n  kidneys? 
We know a l l  t h e  d i f f e r e n t i a l  e f f e c t s  of r a d i a t i o n  and of chemotherapy. With 
chemotherapeutic agents  t h e  t o x i c i t y  t o  t h e  bone marrow i s  d i f f e r e n t  than 
t h e  t o x i c i t y  i n  t h e  gut .  So, t h e r e  a r e  many, many th ings .  We a r e  rushing, 
you know, and I am so r ry  about t h a t  because ou t  of t h a t  rush we may l o s e  a 
chance of f ind ing  t h e  cure  f o r  cancer. We w i l l  g e t  t o o  many sca t t e red  d a t a ,  
and everyone w i l l  g e t  d isgus ted ,  throw h e a t  away, and go t o  another fashion.  
W e  do n o t  follow up a s i n g l e  aspect  and f i n d  t h e  r e a l  answer f o r  it. 
Atkinson: I r e a l l y  do n o t  fol low your log ic .  I do no t  want t o  make t h i s  a 
dialogue,  b u t  I f e e l  compelled t o  comment. You a r e ,  on t h e  one hand, saying 
t h a t  we should be focusing upon t h e  very  expensive, bu t  t echn ica l ly  t r i v i a l ,  
problem of deep i n t e r n a l  organ heat ing  -- before  we have even es tab l i shed  
the  v a l i d i t y  of  t h e  treatment modality. I th ink t h a t  t h i s  shoupd be 
approached i n  a systematic method, such a s  t o  conduct a c l i n i c a l  t r i a l  with 
evaluable les ions .  One of the  d i f f i c u l t i e s  t h a t  we a r e  having i n  our whole- 
body hyperthermia protocol  i s  answering t h e  ques t ion  of how can we t e l l  i f  
we a r e ,  indeed, doing a p a t i e n t  a benef i t ?  And, how can w e  q u a n t i t a t e  t h i s ?  
This i s  a se r ious  problem. For a s u p e r f i c i a l  l e s i o n  t h i s  i s  e a s i l y  measur- 
able .  That i s  why we chose t h i s  approach. Cer ta in ly  we a r e  no t  saying t h a t  
the  method, i f  it i s  e f f e c t i v e ,  w i l l  be r e s t r i c t e d  t o  s u p e r f i c i a l  l e s ions .  
But, t h i s  does seem t o  be t h e  b e s t  way, which we can come up with a t  t h e  
present  t i m e ,  t o  determine whether o r  n o t  it i s  e f f e c t i v e  and t o  j u s t i f y ,  and 
I se r ious ly  mean t h i s ,  t h e  expense involved i n  t h e  t echn ica l ly  t r i v i a l  
problem of deep i n t e r n a l  organ heat ing.  But, I t h ink  t h a t ,  i f  w e  jump i n t o  
deep i n t e r n a l  organ heat ing ,  it might be years  before  we ever answer t h e  
ques t ion  of whether it i s  even e f f e c t i v e .  And, I look a t  t h e  hyperbaric 
oxygen chambers t h a t  a r e  being excessed from h o s p i t a l s  a l l  over t h e  country. 
I see  what happens when you g e t  a l i t t l e  drunk with technology and s t a r t  
g e t t i n g  equipment without  determining whether it i s  e f f e c t i v e ,  o r  how it i s  
b e s t  t o  be  used. That was a se r ious  mistake, and I would no t  l i k e  t o  s e e  t h e  
RTOG do such again. 
Constable: I th ink  t h i s  i s  cor rec t .  D r .  Baker and I have been looking a t  
the  methods you can study c l i n i c a l l y ,  and t h e  only th ing  you r e a l l y  can come 
up with i s  mul t ip le  l e s i o n s  on t h e  su r face ,  a t  the  p resen t  time. A s  we sa id ,  
the re  may be enough genera l  information i n  t h e  l i t e r a t u r e  t o  j u s t i f y  using 
it i n  c e r t a i n  p a l l i a t i v e  s i t u a t i o n s .  But, t o  t r y  to  q u a n t i t a t e  t h a t ,  a s  with 
your whole-body hyperthermia, i s  almost impossible. So, I th ink we have t o  
go along with t h e  skin  t e s t i n g  j u s t  now; and, i f  t h e r e  is  something i n  t h a t ,  
then ,  perhaps, the  e x o t i c  th ings  we have heard may j u s t i f y  themselves i n  due 
course. D r .  Samaras, d i d  you want t o  say something? 
Samaras: I take  exception t o  t h e  f a c t  t h a t  deep heat ing  i s  t echn ica l ly  
t r i v i a l .  Clear ly ,  we have t o  balance cos t -ef fec t iveness  and budgeting, on 
the  one hand, and t h e  development of technology, on t h e  o the r .  But, I cannot 
see  t h a t  deep heat ing by any methodology -- inc luding whole-body hyperthermia, 
which, a t  l e a s t  i n  my mind, i s  s t i l l  quest ionable a s  t o  how uniform t h e  
heat ing,  o r  how w e l l  we con t ro l  t h e  h e a t ,  say a t  t h e  head of t h e  pancreas, o r  
i n  t h e  cen te r  of the  b r a i n  -- i s  a t echn ica l ly  t r i v i a l  problem. I th ink t h a t  
it i s  a very d i f f i c u l t  problem. And, I th ink i n  order  t o  solve these  prob- 
lems, i f  you do want t o  solve these  problems, you a r e  going t o  have t o  expend 
t h e  resources necessary. 
Merz: I would l i k e  t o  add t h a t  I th ink it i s  extremely important t o  pick t h e  
r i g h t  t i s s u e  and t o  go a t  it sys temat ica l ly .  I r e c a l l  not  too  long ago a 
ca tas t rophe.  I th ink about Stanford,  where they s tudied  t h e  e f f e c t  of  
bromodeoxyuridine a s  an analog and a s  an adjunct  t o  radiotherapy.  I n  my 
mind, they picked a l e s i o n ,  a modality of  t reatment,  and a f r a c t i o n a t i o n  sys- 
tem which have denied t h e  use  of bromodeoxyuridine t o  anybody e l s e  who may 
ever want t o  use  it, because it was so  d i sas t rous .  I th ink t h a t  it is a 
necess i ty  t h a t  we look a t  t h e  r i g h t  l e s i o n  i n  t h e  r i g h t  way, so  we can r e a l l y  
'determine whether o r  n o t  t h i s  i s  r e a l l y  useful .  
Regelson: Before t h e  meeting ends I j u s t  want t o  t a l k  about another  approach 
t h a t  does away with microwave instrumentat ion,  o r  ex te rna l  heat ing  from a 
v a r i e t y  of techniques, t o  r a i s e  temperature. W e  a r e  s t a r t i n g  t o  do some col -  
l a b o r a t i v e  work with S l a t e r  from London. S l a t e r ,  a s  you may know, has  found 
t h a t ,  i f  you g ive  d in i t rophenol  with the  r i g h t  d i sp lac ing  agents ,  you g e t  
hea t  o f f  t h e  albumen, depending on t h e  animal species  you use.  You can r a i s e  
t h e  temperature of a r a t ,  f o r  example, t o  44O cent igrade ,  by uncoupling 
ox ida t ive  phosphorylation. I n  f a c t ,  you g e t  i n s t a n t  r i g o r  mor t i s  because you 
have a tremendous accumulation of  l a c t a t e .  We have suggested t h a t  t h i s  be 
used a s  a method t o  meet t h e  energy c r i s i s ,  by p u t t i n g  it i n  r a t  poison. I f  
you have r a t s  i n  your wa l l s ,  you g e t  a l o t  of heat!  But, it represen t s  a 
very i n t e r e s t i n g  opt ion ,  and it i s  extremely i n t r i g u i n g  because uncouplers of 
ox ida t ive  phosphorylation have been around f o r  some t i m e ,  no t  only i n  p l a t e l e t  
physiology, bu t  a l s o  i n  tumor work. Perhaps, some of t h e  e f f e c t s  of warfar in ,  
t h e  coumadins, and some of t h e  quinol ine  d e r i v a t i v e s  'may work i n  t h i s  way a s  
antitumor agents .  So, we a r e  very,  very much i n t e r e s t e d  i n  t h i s .  
Constable: Are t h e r e  any more quest ions? 
Singh: You have debated t h e  usefulness  of hyperthermia. Has t h e  medical 
;community agreed t h a t  it has a mer i t ;  and, i f  it has agreed, why does hyper- 
thermia work? What i s  t h e  b a s i c  reason? Why does,  f o r  example, hyperthermia 
render tumorous c e l l s  more l i a b l e  t o  t reatment by X-radiation o r  chemotherapy? 
Constable: I th ink t h a t  most c l i n i c i a n s  would th ink t h a t  it does have some- 
th ing i n  it, t o  a g r e a t e r  o r  l e s s e r  degree. But, I do n o t  th ink  t h a t  w e  can 
go beyond t h a t  a t  t h i s  time. With regard t o  how it works, you have heard a l l  
t h e  people t a l k i n g  today. D r .  Atkinson may again be the  b e s t  one f o r  t e l l i n g  
us  the  l a t e s t  theory on t h a t .  I have always thought t h a t  it was the  hypoxic 
c e l l s  i n  the  middle t h a t  we were g e t t i n g  a t .  
Singh: Well, I have heard t h e  arguments both ways; and I d id  no t  hear  any- 
th ing  t h a t  says why it works, i f  it does work. 
Constable: D r .  Atkinson, how do you th ink  it works? 
Atkinson: Well, I was j u s t  asking t h e  ques t ion  of  how X-radiation works. 
Would you ca re  t o  dispose of radiotherapy departments because t h i s  ques t ion  
has no t  been f u l l y  e luc idated?  I c a l l  a t t e n t i o n  t o  t h e  f a c t  t h a t  w e  do no t  
even know how a s p i r i n  works! Also, p e n i c i l l i n  was i n  use f o r  a g r e a t  many 
years ,  20 years  approximately, before any ink l ing  was discovered of what i t s  
mechanism of act ion was. I think- t ha t ,  i f  we had sought t o  define the 
mechanism of act ion of o ld  suggested therapeutic modalities before it was 
determined whether they were, i n  f a c t ,  therapeutic modalities, then we could 
have paralyzed medical research around the  world. 
Constable: Yes, I t ra ined with Ralston Paterson, and I remember him teaching 
us t h a t  radiotherapy is, i n  f a c t ,  an empirical science, an a r t  I suppose. 
Although we have gathered and garnered radiobiologis ts  around us by the  
scores and although we ju s t  now, possibly,  know how it works, our methods 
have not r e a l l y  changed. So, it may not be en t i r e ly  necessary t o  answer t h a t  
question before ge t t ing  on with the  c l i n i c a l  s tudies .  
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